| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | metalloendopeptidase activity | ADAMTS2 MMP23B MMP25 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 2.41e-11 | 120 | 132 | 12 | GO:0004222 |
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 5.65e-10 | 16 | 132 | 6 | GO:0023029 | |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 1.88e-09 | 19 | 132 | 6 | GO:0032394 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | ADAMTS2 MMP23B MMP25 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 8.94e-09 | 200 | 132 | 12 | GO:0008237 |
| GeneOntologyMolecularFunction | importin-alpha family protein binding | 2.19e-07 | 21 | 132 | 5 | GO:0061676 | |
| GeneOntologyMolecularFunction | MHC protein binding | 2.27e-06 | 58 | 132 | 6 | GO:0042287 | |
| GeneOntologyMolecularFunction | syntaxin binding | 2.42e-05 | 87 | 132 | 6 | GO:0019905 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ADAMTS2 MMP23B MMP25 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 2.90e-05 | 430 | 132 | 12 | GO:0004175 |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 3.91e-05 | 190 | 132 | 8 | GO:0004252 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 4.48e-05 | 11 | 132 | 3 | GO:0098919 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 7.15e-05 | 207 | 132 | 8 | GO:0008236 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 7.69e-05 | 13 | 132 | 3 | GO:0098879 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 8.45e-05 | 212 | 132 | 8 | GO:0017171 | |
| GeneOntologyMolecularFunction | immune receptor activity | 1.15e-04 | 165 | 132 | 7 | GO:0140375 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.68e-04 | 42 | 132 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.79e-04 | 17 | 132 | 3 | GO:0099508 | |
| GeneOntologyMolecularFunction | protein kinase binding | CDKN2A GOLGA8J HDAC4 DELE1 HDAC7 FAM83H GOLGA8N GOLGA8M GOLGA8H DLG2 DLG4 SMO IRS2 GOLGA8O UTRN NOS1AP | 2.13e-04 | 873 | 132 | 16 | GO:0019901 |
| GeneOntologyMolecularFunction | kinase binding | CDKN2A GOLGA8J HDAC4 PER1 DELE1 HDAC7 FAM83H GOLGA8N GOLGA8M GOLGA8H DLG2 DLG4 SMO IRS2 GOLGA8O UTRN NOS1AP | 2.23e-04 | 969 | 132 | 17 | GO:0019900 |
| GeneOntologyMolecularFunction | zinc ion binding | HDAC4 ADAMTS2 KCMF1 TRPS1 MMP23B GATA1 MMP25 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 UTRN | 2.67e-04 | 891 | 132 | 16 | GO:0008270 |
| GeneOntologyMolecularFunction | SNARE binding | 2.90e-04 | 136 | 132 | 6 | GO:0000149 | |
| GeneOntologyMolecularFunction | phosphatase binding | 3.77e-04 | 264 | 132 | 8 | GO:0019902 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 6.39e-04 | 6 | 132 | 2 | GO:1905030 | |
| GeneOntologyMolecularFunction | tumor necrosis factor binding | 8.91e-04 | 7 | 132 | 2 | GO:0043120 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 1.22e-03 | 32 | 132 | 3 | GO:0099186 | |
| GeneOntologyMolecularFunction | peptidase activity | ADAMTS2 MMP23B MMP25 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 1.34e-03 | 654 | 132 | 12 | GO:0008233 |
| GeneOntologyMolecularFunction | PDZ domain binding | 1.36e-03 | 123 | 132 | 5 | GO:0030165 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF142 ZNF219 HIVEP2 SALL3 ZBTB7C HDAC4 TFAP2E HELT TRPS1 GATA1 PER1 HBP1 POU5F1 TFE3 NCOR1 NFATC2 ZIC5 GLI3 LRRFIP1 EBF4 | 1.45e-03 | 1459 | 132 | 20 | GO:0000977 |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.72e-03 | 36 | 132 | 3 | GO:0019789 | |
| GeneOntologyMolecularFunction | protein domain specific binding | CDKN2A TRPS1 GATA1 POU5F1 ZXDA NCOR1 KCNA1 SHANK2 KCNJ4 DLG2 DLG4 ADAM17 IRS2 NOS1AP | 1.97e-03 | 875 | 132 | 14 | GO:0019904 |
| GeneOntologyMolecularFunction | transition metal ion binding | B4GALT7 HDAC4 ADAMTS2 KCMF1 TRPS1 MMP23B GATA1 MMP25 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 UTRN | 2.17e-03 | 1189 | 132 | 17 | GO:0046914 |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 2.69e-03 | 42 | 132 | 3 | GO:0071889 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 2.75e-03 | 210 | 132 | 6 | GO:0019903 | |
| GeneOntologyMolecularFunction | poly(A)-specific ribonuclease activity | 3.23e-03 | 13 | 132 | 2 | GO:0004535 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF219 HIVEP2 SALL3 ZBTB7C HDAC4 TFAP2E HELT GATA1 PER1 HBP1 POU5F1 TFE3 NFATC2 ZIC5 GLI3 LRRFIP1 EBF4 | 3.46e-03 | 1244 | 132 | 17 | GO:0000978 |
| GeneOntologyMolecularFunction | chromatin binding | SIN3B HDAC4 GATA1 PER1 MSL1 POU5F1 HDAC7 SVEP1 NCOR1 NFATC2 GLI3 SMARCA1 | 3.67e-03 | 739 | 132 | 12 | GO:0003682 |
| GeneOntologyBiologicalProcess | collagen catabolic process | ADAMTS2 MMP23B MMP25 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 3.77e-14 | 53 | 135 | 11 | GO:0030574 |
| GeneOntologyBiologicalProcess | collagen metabolic process | ADAMTS2 MMP23B MMP25 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 3.73e-09 | 148 | 135 | 11 | GO:0032963 |
| GeneOntologyBiologicalProcess | regulation of glycoprotein biosynthetic process | 1.63e-08 | 69 | 135 | 8 | GO:0010559 | |
| GeneOntologyBiologicalProcess | extracellular matrix disassembly | 3.19e-08 | 75 | 135 | 8 | GO:0022617 | |
| GeneOntologyBiologicalProcess | regulation of glycoprotein metabolic process | 5.33e-08 | 80 | 135 | 8 | GO:1903018 | |
| GeneOntologyBiologicalProcess | asymmetric cell division | 8.13e-08 | 34 | 135 | 6 | GO:0008356 | |
| GeneOntologyBiologicalProcess | Golgi disassembly | 8.92e-08 | 18 | 135 | 5 | GO:0090166 | |
| GeneOntologyBiologicalProcess | positive regulation of protein glycosylation | 1.20e-07 | 19 | 135 | 5 | GO:0060050 | |
| GeneOntologyBiologicalProcess | Golgi organization | GOLGA8J GOLGA8T GOLGA8Q GOLGA8N GOLGA8IP GOLGA8M GOLGA8H SEC16A VPS51 GOLGA8O | 1.61e-07 | 168 | 135 | 10 | GO:0007030 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | ADAMTS2 MMP23B MMP25 ZNF469 FSHR MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 ADAMTSL4 | 1.88e-07 | 377 | 135 | 14 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | ADAMTS2 MMP23B MMP25 ZNF469 FSHR MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 ADAMTSL4 | 1.95e-07 | 378 | 135 | 14 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | ADAMTS2 MMP23B MMP25 ZNF469 FSHR MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 ADAMTSL4 | 2.01e-07 | 379 | 135 | 14 | GO:0045229 |
| GeneOntologyBiologicalProcess | Golgi ribbon formation | 3.41e-07 | 23 | 135 | 5 | GO:0090161 | |
| GeneOntologyBiologicalProcess | regulation of protein glycosylation | 4.29e-07 | 24 | 135 | 5 | GO:0060049 | |
| GeneOntologyBiologicalProcess | cellular response to UV-A | 5.59e-07 | 11 | 135 | 4 | GO:0071492 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | CDKN2A GOLGA8J DELE1 NCKAP5L GOLGA8N GOLGA8M GOLGA8H MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 GOLGA8O DNASE2 | 6.02e-07 | 617 | 135 | 17 | GO:0022411 |
| GeneOntologyBiologicalProcess | Golgi localization | 8.02e-07 | 27 | 135 | 5 | GO:0051645 | |
| GeneOntologyBiologicalProcess | meiotic spindle assembly | 9.71e-07 | 28 | 135 | 5 | GO:0090306 | |
| GeneOntologyBiologicalProcess | organelle inheritance | 9.71e-07 | 28 | 135 | 5 | GO:0048308 | |
| GeneOntologyBiologicalProcess | Golgi inheritance | 9.71e-07 | 28 | 135 | 5 | GO:0048313 | |
| GeneOntologyBiologicalProcess | negative regulation of binding | CDKN2A XIRP1 GOLGA8J GATA1 GOLGA8N GOLGA8M GOLGA8H SMO GOLGA8O | 1.82e-06 | 170 | 135 | 9 | GO:0051100 |
| GeneOntologyBiologicalProcess | regulation of binding | CDKN2A XIRP1 GOLGA8J ZBTB7C HDAC4 GATA1 GOLGA8N GOLGA8M GOLGA8H SMO MMP9 GOLGA8O GPSM1 | 2.09e-06 | 396 | 135 | 13 | GO:0051098 |
| GeneOntologyBiologicalProcess | response to UV-A | 2.27e-06 | 15 | 135 | 4 | GO:0070141 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein biosynthetic process | 3.57e-06 | 36 | 135 | 5 | GO:0010560 | |
| GeneOntologyBiologicalProcess | meiotic spindle organization | 4.11e-06 | 37 | 135 | 5 | GO:0000212 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein metabolic process | 6.10e-06 | 40 | 135 | 5 | GO:1903020 | |
| GeneOntologyBiologicalProcess | negative regulation of protein binding | 6.26e-06 | 106 | 135 | 7 | GO:0032091 | |
| GeneOntologyBiologicalProcess | regulation of protein binding | CDKN2A XIRP1 GOLGA8J HDAC4 GOLGA8N GOLGA8M GOLGA8H MMP9 GOLGA8O | 1.97e-05 | 228 | 135 | 9 | GO:0043393 |
| GeneOntologyBiologicalProcess | microtubule nucleation | 3.55e-05 | 57 | 135 | 5 | GO:0007020 | |
| GeneOntologyBiologicalProcess | endomembrane system organization | GOLGA8J GOLGA8T TMEM43 CERT1 GOLGA8Q GOLGA8N GOLGA8IP GOLGA8M GOLGA8H SEC16A PLEC VPS51 GOLGA8O BAIAP3 | 1.34e-04 | 672 | 135 | 14 | GO:0010256 |
| GeneOntologyBiologicalProcess | protein homotetramerization | 1.51e-04 | 77 | 135 | 5 | GO:0051289 | |
| GeneOntologyBiologicalProcess | immune response-regulating signaling pathway | PELI3 KIR2DS2 KIR2DL5B NFATC2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 2.04e-04 | 615 | 135 | 13 | GO:0002764 |
| GeneOntologyBiologicalProcess | regulation of cell development | CDKN2A GOLGA8J HDAC4 HELT GATA1 SEMA3G TFE3 GOLGA8N JAK3 GOLGA8M GLI3 VCAN GOLGA8H FSHR DLG4 SMO MMP14 GOLGA8O | 2.86e-04 | 1095 | 135 | 18 | GO:0060284 |
| GeneOntologyBiologicalProcess | mitotic spindle assembly | 3.48e-04 | 92 | 135 | 5 | GO:0090307 | |
| GeneOntologyBiologicalProcess | optic nerve development | 3.85e-04 | 22 | 135 | 3 | GO:0021554 | |
| GeneOntologyBiologicalProcess | organelle disassembly | 3.97e-04 | 204 | 135 | 7 | GO:1903008 | |
| GeneOntologyBiologicalProcess | presynaptic active zone assembly | 4.20e-04 | 5 | 135 | 2 | GO:1904071 | |
| GeneOntologyBiologicalProcess | myotube cell development | 4.31e-04 | 54 | 135 | 4 | GO:0014904 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | GOLGA8J LRRTM1 GOLGA8N GOLGA8M GLI3 VCAN GOLGA8H DLG4 SMO GOLGA8O | 4.36e-04 | 418 | 135 | 10 | GO:0051962 |
| GeneOntologyBiologicalProcess | vocalization behavior | 5.02e-04 | 24 | 135 | 3 | GO:0071625 | |
| GeneOntologyBiologicalProcess | spindle assembly | 5.17e-04 | 153 | 135 | 6 | GO:0051225 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SIN3B ZNF219 HDAC4 HELT TRPS1 GATA1 PER1 HBP1 POU5F1 PPID HDAC7 NCOR1 ZNF469 NFATC2 GLI3 SMO LRRFIP1 | 5.24e-04 | 1053 | 135 | 17 | GO:0000122 |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 5.48e-04 | 354 | 135 | 9 | GO:0050769 | |
| GeneOntologyBiologicalProcess | glycoprotein biosynthetic process | B4GALT7 GOLGA8J GATA1 GOLGA8N JAK3 GOLGA8M GOLGA8H NECAB3 GOLGA8O | 5.82e-04 | 357 | 135 | 9 | GO:0009101 |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | GOLGA8J HELT SEMA3G GOLGA8N GOLGA8M GLI3 VCAN GOLGA8H DLG4 SMO GOLGA8O | 5.84e-04 | 515 | 135 | 11 | GO:0050767 |
| GeneOntologyBiologicalProcess | positive regulation of cell migration | HDAC4 SEMA3G MSTN HDAC7 FAM83H SMO ADAM17 IRS2 MMP1 SSH2 MMP3 MMP9 MMP14 | 6.17e-04 | 691 | 135 | 13 | GO:0030335 |
| GeneOntologyBiologicalProcess | optic nerve morphogenesis | 6.27e-04 | 6 | 135 | 2 | GO:0021631 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum to Golgi vesicle-mediated transport | 6.33e-04 | 159 | 135 | 6 | GO:0006888 | |
| GeneOntologyBiologicalProcess | protein homooligomerization | 6.93e-04 | 224 | 135 | 7 | GO:0051260 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | GOLGA8J HELT LRRTM1 SEMA3G GOLGA8N GOLGA8M GLI3 VCAN GOLGA8H DLG4 SMO GOLGA8O | 8.41e-04 | 625 | 135 | 12 | GO:0051960 |
| GeneOntologyBiologicalProcess | microtubule polymerization or depolymerization | 8.44e-04 | 168 | 135 | 6 | GO:0031109 | |
| GeneOntologyBiologicalProcess | leukocyte apoptotic process | 8.44e-04 | 168 | 135 | 6 | GO:0071887 | |
| GeneOntologyBiologicalProcess | negative regulation of autophagy | 8.54e-04 | 112 | 135 | 5 | GO:0010507 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 8.89e-04 | 113 | 135 | 5 | GO:0051262 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 9.25e-04 | 114 | 135 | 5 | GO:0050772 | |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | HDAC4 SEMA3G MSTN HDAC7 FAM83H SMO ADAM17 IRS2 MMP1 SSH2 MMP3 MMP9 MMP14 | 9.60e-04 | 725 | 135 | 13 | GO:2000147 |
| GeneOntologyCellularComponent | Golgi cis cisterna | GOLGA8J GOLGA8T GOLGA8Q GOLGA8N GOLGA8IP GOLGA8M GOLGA8H NECAB3 GOLGA8O | 5.77e-13 | 33 | 137 | 9 | GO:0000137 |
| GeneOntologyCellularComponent | Golgi cisterna membrane | B4GALT7 GOLGA8J GOLGA8T GOLGA8Q GOLGA8N GOLGA8IP GOLGA8M GOLGA8H GOLGA8O | 1.14e-08 | 94 | 137 | 9 | GO:0032580 |
| GeneOntologyCellularComponent | Golgi cisterna | B4GALT7 GOLGA8J GOLGA8T GOLGA8Q GOLGA8N GOLGA8IP GOLGA8M GOLGA8H NECAB3 GOLGA8O | 2.06e-08 | 135 | 137 | 10 | GO:0031985 |
| GeneOntologyCellularComponent | cis-Golgi network | GOLGA8J GOLGA8T GOLGA8Q GOLGA8N GOLGA8IP GOLGA8M GOLGA8H GOLGA8O | 8.72e-08 | 85 | 137 | 8 | GO:0005801 |
| GeneOntologyCellularComponent | Golgi stack | B4GALT7 GOLGA8J GOLGA8T GOLGA8Q GOLGA8N GOLGA8IP GOLGA8M GOLGA8H NECAB3 GOLGA8O | 1.93e-07 | 171 | 137 | 10 | GO:0005795 |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | TEPSIN B4GALT7 GOLGA8J GOLGA8T GOLGA8Q GOLGA8N GOLGA8IP GOLGA8M GOLGA8H CLTB NECAB3 BSN VPS51 GOLGA8O BAIAP3 | 2.26e-07 | 443 | 137 | 15 | GO:0098791 |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTS2 MMP23B LAMC3 LRRTM1 SVEP1 MMP25 VCAN LTBP2 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 MUC5AC ADAMTSL4 | 2.99e-07 | 656 | 137 | 18 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTS2 MMP23B LAMC3 LRRTM1 SVEP1 MMP25 VCAN LTBP2 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 MUC5AC ADAMTSL4 | 3.12e-07 | 658 | 137 | 18 | GO:0030312 |
| GeneOntologyCellularComponent | juxtaparanode region of axon | 8.39e-07 | 12 | 137 | 4 | GO:0044224 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 8.70e-05 | 110 | 137 | 6 | GO:0030134 | |
| GeneOntologyCellularComponent | transcription repressor complex | 2.70e-04 | 87 | 137 | 5 | GO:0017053 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 3.33e-04 | 91 | 137 | 5 | GO:0008076 | |
| GeneOntologyCellularComponent | spindle pole | 4.13e-04 | 205 | 137 | 7 | GO:0000922 | |
| GeneOntologyCellularComponent | synaptic membrane | LRRTM1 PCDH17 KCNA1 KCNA2 SHANK2 KCNJ4 CLTB SCN10A DLG2 DLG4 BSN UTRN | 4.64e-04 | 583 | 137 | 12 | GO:0097060 |
| GeneOntologyCellularComponent | early endosome membrane | 5.05e-04 | 212 | 137 | 7 | GO:0031901 | |
| GeneOntologyCellularComponent | potassium channel complex | 6.15e-04 | 104 | 137 | 5 | GO:0034705 | |
| GeneOntologyCellularComponent | axon initial segment | 8.88e-04 | 29 | 137 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.43e-03 | 405 | 137 | 9 | GO:0045211 | |
| GeneOntologyCellularComponent | mitotic spindle | 2.13e-03 | 201 | 137 | 6 | GO:0072686 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | TEPSIN ATP10B MMP25 MS4A3 KCNJ4 CLTB SEC16A DLG2 DLG4 SMO KIR2DL1 KIR2DL3 KIR2DL4 BSN KIR2DS4 KIR3DL1 KIR3DL2 BAIAP3 | 2.23e-03 | 1307 | 137 | 18 | GO:0030659 |
| GeneOntologyCellularComponent | histone deacetylase complex | 2.37e-03 | 85 | 137 | 4 | GO:0000118 | |
| GeneOntologyCellularComponent | vesicle membrane | TEPSIN ATP10B MMP25 MS4A3 KCNJ4 CLTB SEC16A DLG2 DLG4 SMO KIR2DL1 KIR2DL3 KIR2DL4 BSN KIR2DS4 KIR3DL1 KIR3DL2 BAIAP3 | 2.58e-03 | 1325 | 137 | 18 | GO:0012506 |
| GeneOntologyCellularComponent | coated vesicle | 2.61e-03 | 360 | 137 | 8 | GO:0030135 | |
| GeneOntologyCellularComponent | main axon | 2.80e-03 | 89 | 137 | 4 | GO:0044304 | |
| HumanPheno | Hip dysplasia | HIVEP2 HDAC4 ADAMTS2 TRPS1 MMP23B TFE3 ZNF469 ATRIP GLI3 MMP13 | 3.45e-05 | 247 | 44 | 10 | HP:0001385 |
| HumanPheno | Atypical scarring of skin | 3.49e-05 | 74 | 44 | 6 | HP:0000987 | |
| MousePheno | increased alveolar macrophage number | 3.74e-08 | 14 | 103 | 5 | MP:0014228 | |
| MousePheno | abnormal alveolar macrophage number | 5.58e-08 | 15 | 103 | 5 | MP:0014227 | |
| MousePheno | abnormal Golgi vesicle transport | 4.69e-07 | 22 | 103 | 5 | MP:0030949 | |
| MousePheno | abnormal proacrosomal vesicle fusion | 7.49e-07 | 24 | 103 | 5 | MP:0031355 | |
| MousePheno | abnormal alveolar macrophage morphology | 1.40e-06 | 27 | 103 | 5 | MP:0008245 | |
| MousePheno | absent sperm mitochondrial sheath | 1.69e-06 | 28 | 103 | 5 | MP:0009833 | |
| MousePheno | abnormal lung epithelium morphology | 2.47e-06 | 118 | 103 | 8 | MP:0006382 | |
| MousePheno | absent acrosome | 3.39e-06 | 32 | 103 | 5 | MP:0008839 | |
| MousePheno | abnormal Golgi apparatus morphology | 3.97e-06 | 33 | 103 | 5 | MP:0011743 | |
| MousePheno | abnormal actin cytoskeleton morphology | 4.62e-06 | 34 | 103 | 5 | MP:0020849 | |
| MousePheno | abnormal brain wave pattern | 7.33e-06 | 64 | 103 | 6 | MP:0004994 | |
| MousePheno | abnormal sperm nucleus morphology | 1.71e-05 | 74 | 103 | 6 | MP:0009232 | |
| MousePheno | abnormal microtubule cytoskeleton morphology | 2.12e-05 | 46 | 103 | 5 | MP:0020850 | |
| MousePheno | abnormal pulmonary alveolus epithelial cell morphology | 2.15e-05 | 77 | 103 | 6 | MP:0002273 | |
| MousePheno | abnormal pulmonary alveolus epithelium morphology | 2.67e-05 | 80 | 103 | 6 | MP:0010898 | |
| MousePheno | pulmonary fibrosis | 3.54e-05 | 51 | 103 | 5 | MP:0006050 | |
| MousePheno | delayed tooth eruption | 4.49e-05 | 10 | 103 | 3 | MP:0003053 | |
| MousePheno | abnormal pulmonary alveolar parenchyma morphology | 5.22e-05 | 90 | 103 | 6 | MP:0010901 | |
| MousePheno | abnormal respiratory epithelium morphology | GOLGA8J TRPS1 GOLGA8N GOLGA8M GLI3 GOLGA8H ADAM17 MMP14 GOLGA8O | 5.86e-05 | 235 | 103 | 9 | MP:0010942 |
| MousePheno | abnormal surfactant physiology | 6.62e-05 | 58 | 103 | 5 | MP:0004782 | |
| MousePheno | immotile sperm | 7.19e-05 | 59 | 103 | 5 | MP:0020869 | |
| MousePheno | decreased Purkinje cell number | 1.32e-04 | 67 | 103 | 5 | MP:0000880 | |
| MousePheno | abnormal type II pneumocyte morphology | 1.32e-04 | 67 | 103 | 5 | MP:0002275 | |
| MousePheno | abnormal Purkinje cell number | 1.52e-04 | 69 | 103 | 5 | MP:0000878 | |
| MousePheno | increased width of hypertrophic chondrocyte zone | 1.88e-04 | 39 | 103 | 4 | MP:0003408 | |
| MousePheno | globozoospermia | 2.12e-04 | 74 | 103 | 5 | MP:0002686 | |
| MousePheno | abnormal cell cytoskeleton morphology | 2.26e-04 | 75 | 103 | 5 | MP:0020378 | |
| MousePheno | liver fibrosis | 2.56e-04 | 77 | 103 | 5 | MP:0003333 | |
| MousePheno | abnormal skin morphology | CDKN2A SALL3 ERN1 ADAMTS2 MOGAT2 TRPS1 GATA1 LRRTM1 SVEP1 FAM83H NCOR1 GLI3 VCAN FSHR SMO ADAM17 PLEC PAN3 MMP11 MMP14 MMP15 GPSM1 LRRFIP1 | 3.09e-04 | 1455 | 103 | 23 | MP:0002060 |
| MousePheno | premature lambdoid suture closure | 3.20e-04 | 4 | 103 | 2 | MP:0030356 | |
| MousePheno | abnormal folding of telencephalic vesicles | 3.20e-04 | 4 | 103 | 2 | MP:0000935 | |
| MousePheno | abnormal optic vesicle formation | 3.89e-04 | 47 | 103 | 4 | MP:0003425 | |
| MousePheno | abnormal action potential | 4.45e-04 | 133 | 103 | 6 | MP:0005402 | |
| MousePheno | abnormal synaptic vesicle morphology | 5.32e-04 | 51 | 103 | 4 | MP:0004769 | |
| MousePheno | abnormal wound healing | 5.56e-04 | 193 | 103 | 7 | MP:0005023 | |
| MousePheno | abnormal acrosome assembly | 5.83e-04 | 92 | 103 | 5 | MP:0031354 | |
| MousePheno | abnormal sperm mitochondrial sheath morphology | 6.75e-04 | 95 | 103 | 5 | MP:0009832 | |
| MousePheno | prolonged QT interval | 7.10e-04 | 55 | 103 | 4 | MP:0003233 | |
| MousePheno | abnormal nervous system electrophysiology | 7.16e-04 | 329 | 103 | 9 | MP:0002272 | |
| MousePheno | abnormal cerebellar layer morphology | 7.19e-04 | 263 | 103 | 8 | MP:0009956 | |
| MousePheno | ataxia | 7.74e-04 | 266 | 103 | 8 | MP:0001393 | |
| MousePheno | lens dislocation | 7.91e-04 | 6 | 103 | 2 | MP:0031428 | |
| MousePheno | increased blinking frequency | 7.91e-04 | 6 | 103 | 2 | MP:0001994 | |
| MousePheno | nuchal edema | 7.91e-04 | 6 | 103 | 2 | MP:0012269 | |
| Domain | M10A_MMP | 1.99e-16 | 23 | 130 | 10 | IPR033739 | |
| Domain | Pept_M10A | 1.99e-16 | 23 | 130 | 10 | IPR021190 | |
| Domain | Peptidase_M10 | 3.39e-16 | 24 | 130 | 10 | PF00413 | |
| Domain | Peptidase_Metallo | 3.36e-15 | 29 | 130 | 10 | IPR006026 | |
| Domain | ZnMc | 3.36e-15 | 29 | 130 | 10 | SM00235 | |
| Domain | Pept_M10_metallopeptidase | MMP23B MMP25 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 5.75e-15 | 43 | 130 | 11 | IPR001818 |
| Domain | Hemopexin-like_dom | 2.18e-14 | 23 | 130 | 9 | IPR000585 | |
| Domain | Hemopexin-like_repeat | 2.18e-14 | 23 | 130 | 9 | IPR018487 | |
| Domain | HEMOPEXIN | 2.18e-14 | 23 | 130 | 9 | PS00024 | |
| Domain | - | 2.18e-14 | 23 | 130 | 9 | 2.110.10.10 | |
| Domain | HEMOPEXIN_2 | 2.18e-14 | 23 | 130 | 9 | PS51642 | |
| Domain | HX | 2.18e-14 | 23 | 130 | 9 | SM00120 | |
| Domain | Hemopexin | 2.18e-14 | 23 | 130 | 9 | PF00045 | |
| Domain | Pept_M10A_Zn_BS | 2.74e-14 | 15 | 130 | 8 | IPR021158 | |
| Domain | Hemopexin_CS | 1.02e-13 | 17 | 130 | 8 | IPR018486 | |
| Domain | CYSTEINE_SWITCH | 1.75e-13 | 41 | 130 | 10 | PS00546 | |
| Domain | Pept_M10A_stromelysin-type | 1.83e-13 | 18 | 130 | 8 | IPR016293 | |
| Domain | - | ADAMTS2 MMP23B MMP25 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 3.63e-13 | 81 | 130 | 12 | 3.40.390.10 |
| Domain | MetalloPept_cat_dom | ADAMTS2 MMP23B MMP25 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 3.63e-13 | 81 | 130 | 12 | IPR024079 |
| Domain | PG_binding_1 | 5.20e-13 | 20 | 130 | 8 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 5.20e-13 | 20 | 130 | 8 | IPR002477 | |
| Domain | ZINC_PROTEASE | ADAMTS2 MMP23B MMP25 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 3.77e-12 | 98 | 130 | 12 | PS00142 |
| Domain | ig | KIR2DS2 SEMA3G KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 9.17e-08 | 190 | 130 | 11 | PF00047 |
| Domain | Immunoglobulin | KIR2DS2 SEMA3G KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 9.17e-08 | 190 | 130 | 11 | IPR013151 |
| Domain | GOLGA2L5 | 1.20e-07 | 18 | 130 | 5 | PF15070 | |
| Domain | Golgin_A | 1.20e-07 | 18 | 130 | 5 | IPR024858 | |
| Domain | IG | MMP23B KIR2DS2 SEMA3G VCAN KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 LY9 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 1.43e-06 | 421 | 130 | 14 | SM00409 |
| Domain | Ig_sub | MMP23B KIR2DS2 SEMA3G VCAN KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 LY9 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 1.43e-06 | 421 | 130 | 14 | IPR003599 |
| Domain | Ig-like_fold | MMP23B KIR2DS2 SEMA3G SHANK2 NFATC2 VCAN KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 LY9 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 EBF4 | 8.19e-06 | 706 | 130 | 17 | IPR013783 |
| Domain | Ig-like_dom | MMP23B KIR2DS2 SEMA3G VCAN KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 LY9 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 1.11e-05 | 503 | 130 | 14 | IPR007110 |
| Domain | - | MMP23B KIR2DS2 SEMA3G NFATC2 VCAN KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 LY9 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 EBF4 | 1.50e-05 | 663 | 130 | 16 | 2.60.40.10 |
| Domain | IG_LIKE | MMP23B KIR2DS2 SEMA3G VCAN KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 LY9 KIR2DS4 KIR3DL1 KIR3DL2 | 3.89e-05 | 491 | 130 | 13 | PS50835 |
| Domain | MAGUK_N_PEST | 2.86e-04 | 4 | 130 | 2 | PF10608 | |
| Domain | PDZ_assoc | 2.86e-04 | 4 | 130 | 2 | PF10600 | |
| Domain | DLG1_PEST_dom | 2.86e-04 | 4 | 130 | 2 | IPR019590 | |
| Domain | PDZ_assoc | 2.86e-04 | 4 | 130 | 2 | IPR019583 | |
| Domain | MAGUK_N_PEST | 2.86e-04 | 4 | 130 | 2 | SM01277 | |
| Domain | DLG1 | 2.86e-04 | 4 | 130 | 2 | IPR016313 | |
| Domain | DUF3377 | 2.86e-04 | 4 | 130 | 2 | PF11857 | |
| Domain | Histone_deAcase_II_euk | 2.86e-04 | 4 | 130 | 2 | IPR017320 | |
| Domain | Pept_M10A_metallopeptidase_C | 2.86e-04 | 4 | 130 | 2 | IPR021805 | |
| Domain | K_chnl_volt-dep_Kv1 | 1.31e-03 | 8 | 130 | 2 | IPR003972 | |
| Domain | Hist_deacetyl | 2.54e-03 | 11 | 130 | 2 | PF00850 | |
| Domain | - | 2.54e-03 | 11 | 130 | 2 | 3.40.800.20 | |
| Domain | His_deacetylse_dom | 2.54e-03 | 11 | 130 | 2 | IPR023801 | |
| Domain | His_deacetylse | 2.54e-03 | 11 | 130 | 2 | IPR000286 | |
| Pathway | WP_MATRIX_METALLOPROTEINASES | 7.34e-15 | 29 | 107 | 10 | MM15981 | |
| Pathway | WP_MATRIX_METALLOPROTEINASES | 1.09e-14 | 30 | 107 | 10 | M39652 | |
| Pathway | WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION | MMP23B MMP25 SCN10A MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 3.04e-14 | 46 | 107 | 11 | M46450 |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | 1.97e-12 | 33 | 107 | 9 | M26976 | |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | 8.06e-12 | 38 | 107 | 9 | MM14611 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.16e-09 | 64 | 107 | 9 | M26953 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 5.65e-09 | 53 | 107 | 8 | MM14566 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | ADAMTS2 LAMC3 MMP25 VCAN ADAM17 LTBP2 MMP1 MMP3 PLEC MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 7.61e-09 | 300 | 107 | 15 | M610 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.05e-07 | 140 | 107 | 10 | M587 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.99e-07 | 114 | 107 | 9 | MM14571 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 | 3.29e-07 | 88 | 107 | 8 | M16004 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | ADAMTS2 MMP25 VCAN LTBP2 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 5.81e-07 | 258 | 107 | 12 | MM14572 |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 6.02e-07 | 41 | 107 | 6 | M13519 | |
| Pathway | REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION | 6.92e-07 | 23 | 107 | 5 | MM14620 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | NFATC2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 | 9.51e-07 | 137 | 107 | 9 | M5669 |
| Pathway | REACTOME_DAP12_INTERACTIONS | 3.19e-06 | 54 | 107 | 6 | MM14871 | |
| Pathway | WP_15Q11Q13_COPY_NUMBER_VARIATION | 5.40e-06 | 59 | 107 | 6 | M48104 | |
| Pathway | REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT | 3.90e-05 | 83 | 107 | 6 | MM14819 | |
| Pathway | REACTOME_RHOD_GTPASE_CYCLE | 1.23e-04 | 64 | 107 | 5 | MM15601 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 1.42e-04 | 66 | 107 | 5 | M101 | |
| Pathway | PID_FRA_PATHWAY | 1.71e-04 | 37 | 107 | 4 | M65 | |
| Pathway | WP_IL18_SIGNALING | 2.30e-04 | 273 | 107 | 9 | M39818 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 4.01e-04 | 46 | 107 | 4 | M27151 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 5.65e-04 | 135 | 107 | 6 | MM14781 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 6.04e-04 | 90 | 107 | 5 | M631 | |
| Pathway | WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME | 6.74e-04 | 23 | 107 | 3 | M39883 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 8.51e-04 | 56 | 107 | 4 | M27616 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 9.71e-04 | 58 | 107 | 4 | M29616 | |
| Pathway | KEGG_MEDICUS_VARIANT_TMPRSS2_ERG_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION | 1.17e-03 | 7 | 107 | 2 | M47443 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.17e-03 | 61 | 107 | 4 | M27103 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.21e-03 | 28 | 107 | 3 | M6177 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS | 1.32e-03 | 63 | 107 | 4 | M39884 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION | 1.32e-03 | 63 | 107 | 4 | M39646 | |
| Pathway | WP_ONCOSTATIN_M_SIGNALING | 1.49e-03 | 65 | 107 | 4 | M39562 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.49e-03 | 110 | 107 | 5 | MM15350 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION | 1.58e-03 | 66 | 107 | 4 | MM15875 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 1.64e-03 | 31 | 107 | 3 | M39522 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.75e-03 | 114 | 107 | 5 | MM15361 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 1.76e-03 | 168 | 107 | 6 | MM14785 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 1.80e-03 | 32 | 107 | 3 | M39521 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 1.80e-03 | 32 | 107 | 3 | MM15326 | |
| Pubmed | Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. | KIR2DS2 KIR2DL5B KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 3.10e-23 | 17 | 138 | 11 | 20878400 |
| Pubmed | KIR2DS2 KIR2DL5B KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 3.10e-23 | 17 | 138 | 11 | 19450876 | |
| Pubmed | KIR2DS2 KIR2DL5B KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 3.10e-23 | 17 | 138 | 11 | 19761533 | |
| Pubmed | KIR2DS2 KIR2DL5B KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 3.10e-23 | 17 | 138 | 11 | 20650299 | |
| Pubmed | [Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese]. | KIR2DS2 KIR2DL5B KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 3.10e-23 | 17 | 138 | 11 | 19218127 |
| Pubmed | Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. | KIR2DS2 KIR2DL5B KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 4.16e-22 | 20 | 138 | 11 | 20193031 |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 6.85e-22 | 14 | 138 | 10 | 19875891 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 6.85e-22 | 14 | 138 | 10 | 19489269 | |
| Pubmed | Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 6.85e-22 | 14 | 138 | 10 | 15896204 |
| Pubmed | KIR2DS2 KIR2DL5B KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 1.74e-21 | 22 | 138 | 11 | 20492596 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 2.05e-21 | 15 | 138 | 10 | 20082646 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 2.05e-21 | 15 | 138 | 10 | 20356536 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 2.05e-21 | 15 | 138 | 10 | 19926642 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 2.05e-21 | 15 | 138 | 10 | 20643584 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 2.05e-21 | 15 | 138 | 10 | 19326408 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 5.44e-21 | 16 | 138 | 10 | 19897003 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 5.44e-21 | 16 | 138 | 10 | 19309280 | |
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population]. | KIR2DS2 KIR2DL5B KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 | 5.44e-21 | 16 | 138 | 10 | 16403292 |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 5.44e-21 | 16 | 138 | 10 | 20652381 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 5.44e-21 | 16 | 138 | 10 | 17868255 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 5.44e-21 | 16 | 138 | 10 | 20331834 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 5.44e-21 | 16 | 138 | 10 | 19000141 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 5.44e-21 | 16 | 138 | 10 | 20670355 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 5.44e-21 | 16 | 138 | 10 | 18668235 | |
| Pubmed | Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage. | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 5.44e-21 | 16 | 138 | 10 | 19527230 |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 5.44e-21 | 16 | 138 | 10 | 19279038 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 5.44e-21 | 16 | 138 | 10 | 18643961 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 5.44e-21 | 16 | 138 | 10 | 20210919 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 1.32e-20 | 17 | 138 | 10 | 19968064 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 1.32e-20 | 17 | 138 | 10 | 20483367 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 1.32e-20 | 17 | 138 | 10 | 20173792 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 2.96e-20 | 18 | 138 | 10 | 20580654 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 2.96e-20 | 18 | 138 | 10 | 20519398 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 2.96e-20 | 18 | 138 | 10 | 19846535 | |
| Pubmed | Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 2.96e-20 | 18 | 138 | 10 | 19630074 |
| Pubmed | KIR2DS2 KIR2DL5B KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 | 2.96e-20 | 18 | 138 | 10 | 20200544 | |
| Pubmed | Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians. | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 2.96e-20 | 18 | 138 | 10 | 19046302 |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 2.96e-20 | 18 | 138 | 10 | 20210918 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DS1 | 4.07e-20 | 12 | 138 | 9 | 20371502 | |
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia]. | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 4.07e-20 | 12 | 138 | 9 | 17490516 |
| Pubmed | KIR haplotype content at the allele level in 77 Northern Irish families. | KIR2DS2 KIR2DL5A KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DS1 | 5.00e-20 | 8 | 138 | 8 | 17200871 |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 6.22e-20 | 19 | 138 | 10 | 20600442 | |
| Pubmed | KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 6.22e-20 | 19 | 138 | 10 | 18571006 |
| Pubmed | Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil. | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 6.22e-20 | 19 | 138 | 10 | 18778326 |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 6.22e-20 | 19 | 138 | 10 | 18848853 | |
| Pubmed | KIR2DS2 KIR2DL5B KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 1.24e-19 | 20 | 138 | 10 | 20426625 | |
| Pubmed | KIR2DS2 KIR2DL5B KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DS1 | 1.32e-19 | 13 | 138 | 9 | 19120281 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 2.36e-19 | 21 | 138 | 10 | 19861144 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 3.68e-19 | 14 | 138 | 9 | 18945962 | |
| Pubmed | Functional interactions between matrix metalloproteinases and glycosaminoglycans. | 4.31e-19 | 22 | 138 | 10 | 23421805 | |
| Pubmed | 4.31e-19 | 22 | 138 | 10 | 10419448 | ||
| Pubmed | KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations. | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 | 9.17e-19 | 15 | 138 | 9 | 17498266 |
| Pubmed | KIR2DS2 KIR2DL5B KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 9.83e-19 | 35 | 138 | 11 | 19683555 | |
| Pubmed | KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 4.43e-18 | 17 | 138 | 9 | 19032228 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL2 KIR3DS1 | 4.43e-18 | 17 | 138 | 9 | 20173784 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DS1 | 4.43e-18 | 17 | 138 | 9 | 19169284 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DS1 | 8.17e-18 | 11 | 138 | 8 | 18830515 | |
| Pubmed | [Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients]. | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DS1 | 8.17e-18 | 11 | 138 | 8 | 19664392 |
| Pubmed | Immunogenetic characteristics of patients with autoimmune gastritis. | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 1.30e-17 | 29 | 138 | 10 | 20082482 |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DS1 | 2.44e-17 | 12 | 138 | 8 | 19936734 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 2.44e-17 | 12 | 138 | 8 | 20137308 | |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DS1 | 6.33e-17 | 13 | 138 | 8 | 18687225 | |
| Pubmed | 1.06e-16 | 8 | 138 | 7 | 15730517 | ||
| Pubmed | Multiple sclerosis associates with LILRA3 deletion in Spanish patients. | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DS1 | 1.47e-16 | 14 | 138 | 8 | 19421224 |
| Pubmed | 1.62e-16 | 36 | 138 | 10 | 20587546 | ||
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DS1 | 3.14e-16 | 15 | 138 | 8 | 19850842 | |
| Pubmed | Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma. | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DS1 | 3.14e-16 | 15 | 138 | 8 | 20207982 |
| Pubmed | KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DS1 | 3.14e-16 | 15 | 138 | 8 | 19493232 | |
| Pubmed | 4.75e-16 | 9 | 138 | 7 | 7749980 | ||
| Pubmed | Alternatively spliced forms of human killer inhibitory receptors. | 4.75e-16 | 9 | 138 | 7 | 8662091 | |
| Pubmed | 6.27e-16 | 16 | 138 | 8 | 10949577 | ||
| Pubmed | 6.27e-16 | 16 | 138 | 8 | 37701782 | ||
| Pubmed | 1.58e-15 | 10 | 138 | 7 | 12559621 | ||
| Pubmed | Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome. | 1.03e-14 | 12 | 138 | 7 | 19181658 | |
| Pubmed | 2.23e-14 | 13 | 138 | 7 | 19934297 | ||
| Pubmed | 2.44e-14 | 7 | 138 | 6 | 12618911 | ||
| Pubmed | 2.44e-14 | 7 | 138 | 6 | 14607943 | ||
| Pubmed | Expression of a killer cell receptor-like gene in plastic regions of the central nervous system. | 2.44e-14 | 7 | 138 | 6 | 15748957 | |
| Pubmed | Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors. | 2.44e-14 | 7 | 138 | 6 | 11169255 | |
| Pubmed | 2.44e-14 | 7 | 138 | 6 | 26928464 | ||
| Pubmed | 3.49e-14 | 24 | 138 | 8 | 15734845 | ||
| Pubmed | 9.73e-14 | 8 | 138 | 6 | 9430221 | ||
| Pubmed | KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer. | 9.14e-13 | 5 | 138 | 5 | 27893413 | |
| Pubmed | 9.14e-13 | 5 | 138 | 5 | 7716543 | ||
| Pubmed | 5.87e-12 | 13 | 138 | 6 | 12815621 | ||
| Pubmed | 1.91e-11 | 7 | 138 | 5 | 17307908 | ||
| Pubmed | 1.91e-11 | 7 | 138 | 5 | 9430220 | ||
| Pubmed | 1.91e-11 | 7 | 138 | 5 | 11113146 | ||
| Pubmed | 1.91e-11 | 7 | 138 | 5 | 8216228 | ||
| Pubmed | 1.91e-11 | 7 | 138 | 5 | 25770908 | ||
| Pubmed | 2.71e-11 | 16 | 138 | 6 | 20484597 | ||
| Pubmed | 5.07e-11 | 8 | 138 | 5 | 18681957 | ||
| Pubmed | ATXN1 protein family and CIC regulate extracellular matrix remodeling and lung alveolarization. | 9.09e-11 | 19 | 138 | 6 | 22014525 | |
| Pubmed | 1.14e-10 | 9 | 138 | 5 | 18074414 | ||
| Pubmed | 1.14e-10 | 9 | 138 | 5 | 18186800 | ||
| Pubmed | 1.14e-10 | 9 | 138 | 5 | 18340360 | ||
| Pubmed | 2.27e-10 | 10 | 138 | 5 | 21206914 | ||
| Pubmed | [The system of matrix metalloproteinases and their role in patients with pulmonary tuberculosis]. | 2.37e-10 | 4 | 138 | 4 | 27797337 | |
| Pubmed | 2.37e-10 | 4 | 138 | 4 | 18718052 | ||
| Pubmed | Polymorphism and domain variability of human killer cell inhibitory receptors. | 2.37e-10 | 4 | 138 | 4 | 9059894 | |
| Interaction | MMP24 interactions | 2.08e-11 | 19 | 132 | 7 | int:MMP24 | |
| Interaction | MMP8 interactions | 1.92e-10 | 25 | 132 | 7 | int:MMP8 | |
| Interaction | MMP11 interactions | 8.53e-09 | 12 | 132 | 5 | int:MMP11 | |
| Interaction | KIR2DL2 interactions | 1.38e-08 | 13 | 132 | 5 | int:KIR2DL2 | |
| Interaction | MMP16 interactions | 8.94e-08 | 18 | 132 | 5 | int:MMP16 | |
| Interaction | KIR3DL1 interactions | 1.20e-06 | 13 | 132 | 4 | int:KIR3DL1 | |
| Interaction | MMP13 interactions | 1.66e-06 | 31 | 132 | 5 | int:MMP13 | |
| Interaction | BCAN interactions | 3.58e-06 | 36 | 132 | 5 | int:BCAN | |
| Interaction | CCL7 interactions | 1.17e-05 | 22 | 132 | 4 | int:CCL7 | |
| Interaction | ACAN interactions | 1.17e-05 | 22 | 132 | 4 | int:ACAN | |
| Interaction | MMP7 interactions | 1.23e-05 | 46 | 132 | 5 | int:MMP7 | |
| Interaction | CDK2AP1 interactions | 1.27e-05 | 118 | 132 | 7 | int:CDK2AP1 | |
| Interaction | MMP2 interactions | 2.30e-05 | 87 | 132 | 6 | int:MMP2 | |
| Interaction | MMP10 interactions | 4.22e-05 | 30 | 132 | 4 | int:MMP10 | |
| Interaction | MMP27 interactions | 4.36e-05 | 11 | 132 | 3 | int:MMP27 | |
| Interaction | MMP25 interactions | 7.49e-05 | 13 | 132 | 3 | int:MMP25 | |
| Interaction | CTBP1 interactions | ZNF219 HDAC4 FBF1 TRPS1 POU5F1 NCKAP5L HDAC7 NCOR1 NFATC2 SEC16A VPS51 | 7.58e-05 | 406 | 132 | 11 | int:CTBP1 |
| Interaction | MMP9 interactions | 7.79e-05 | 67 | 132 | 5 | int:MMP9 | |
| Interaction | KCNA4 interactions | 8.37e-05 | 68 | 132 | 5 | int:KCNA4 | |
| Interaction | HAPLN1 interactions | 9.48e-05 | 14 | 132 | 3 | int:HAPLN1 | |
| Interaction | MMP1 interactions | 9.82e-05 | 37 | 132 | 4 | int:MMP1 | |
| Interaction | GATAD2A interactions | 1.16e-04 | 224 | 132 | 8 | int:GATAD2A | |
| Interaction | CCL2 interactions | 1.21e-04 | 39 | 132 | 4 | int:CCL2 | |
| Interaction | MMP3 interactions | 1.21e-04 | 39 | 132 | 4 | int:MMP3 | |
| Interaction | TIMP1 interactions | 1.34e-04 | 40 | 132 | 4 | int:TIMP1 | |
| Interaction | MBD3 interactions | 1.44e-04 | 295 | 132 | 9 | int:MBD3 | |
| Interaction | DLGAP1 interactions | 1.86e-04 | 180 | 132 | 7 | int:DLGAP1 | |
| Interaction | GATAD2B interactions | 2.15e-04 | 245 | 132 | 8 | int:GATAD2B | |
| Interaction | TAFA2 interactions | 2.52e-04 | 47 | 132 | 4 | int:TAFA2 | |
| Interaction | KIR3DP1 interactions | 2.53e-04 | 4 | 132 | 2 | int:KIR3DP1 | |
| Cytoband | 19q13.4 | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 2.83e-12 | 79 | 139 | 9 | 19q13.4 |
| Cytoband | 15q13.2 | 4.63e-09 | 21 | 139 | 5 | 15q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q13 | 2.54e-08 | 100 | 139 | 7 | chr15q13 | |
| Cytoband | 11q22.3 | 9.94e-06 | 44 | 139 | 4 | 11q22.3 | |
| Cytoband | 9q34.3 | 3.15e-04 | 106 | 139 | 4 | 9q34.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q22 | 3.26e-04 | 107 | 139 | 4 | chr11q22 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | KIR2DS2 KIR2DL5B KIR2DL5A KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 | 6.71e-22 | 18 | 89 | 11 | 620 |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 9.19e-18 | 24 | 89 | 10 | 891 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | KIR2DS2 KIR2DL5A ADAM17 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 LY9 KIR2DS4 KIR3DL1 KIR3DL2 | 3.65e-06 | 394 | 89 | 11 | 471 |
| GeneFamily | Histone deacetylases, class IIA | 1.43e-04 | 4 | 89 | 2 | 992 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.41e-03 | 15 | 89 | 2 | 82 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF142 ZNF219 HIVEP2 SALL3 ZBTB7C TRPS1 ZXDA ZNF469 ZIC5 GLI3 | 2.75e-03 | 718 | 89 | 10 | 28 |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.48e-03 | 18 | 89 | 2 | 91 | |
| Coexpression | NABA_ECM_REGULATORS | ADAMTS2 MMP23B MMP25 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 ADAMTSL4 | 4.06e-10 | 238 | 137 | 13 | M3468 |
| Coexpression | NABA_ECM_REGULATORS | ADAMTS2 MMP23B MMP25 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 ADAMTSL4 | 4.98e-10 | 242 | 137 | 13 | MM17062 |
| Coexpression | KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE | 6.53e-09 | 49 | 137 | 7 | M40909 | |
| Coexpression | NABA_MATRISOME | ADAMTS2 MMP23B LAMC3 SEMA3G MSTN SVEP1 MMP25 VCAN ADAM17 LTBP2 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 MUC5AC ADAMTSL4 | 3.04e-07 | 1008 | 137 | 20 | MM17056 |
| Coexpression | NABA_MATRISOME | ADAMTS2 MMP23B LAMC3 SEMA3G MSTN SVEP1 MMP25 VCAN ADAM17 LTBP2 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 MUC5AC ADAMTSL4 | 4.02e-07 | 1026 | 137 | 20 | M5889 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | CDKN2A SALL3 ZBTB7C ADAMTS2 CARHSP1 PPP1R3B MMP23B LAMC3 SVEP1 PCDH17 MMP25 NFATC2 ZIC5 KCNJ4 GLI3 SMO MMP14 C6orf141 UTRN EBF4 | 8.20e-07 | 1074 | 137 | 20 | M1941 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS2 MMP23B SEMA3G MSTN MMP25 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 MUC5AC ADAMTSL4 | 1.66e-06 | 738 | 137 | 16 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS2 MMP23B SEMA3G MSTN MMP25 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 MUC5AC ADAMTSL4 | 2.08e-06 | 751 | 137 | 16 | M5885 |
| Coexpression | HALLMARK_COAGULATION | 8.38e-06 | 138 | 137 | 7 | M5946 | |
| Coexpression | GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP | 1.04e-05 | 199 | 137 | 8 | M9269 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 1.45e-05 | 59 | 137 | 5 | M47989 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_UP | 1.94e-05 | 157 | 137 | 7 | M7731 | |
| Coexpression | GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN | 8.75e-05 | 199 | 137 | 7 | M9885 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CD16_POS_NK_CELL | 1.08e-04 | 18 | 137 | 3 | M45763 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | B4GALT7 HIVEP2 CDC42EP4 ZBTB7C ADAMTS2 SZT2 TRPS1 PER1 IP6K1 TNRC6C NCKAP5L HDAC7 SVEP1 PCDH17 TTC7B GLI3 VCAN SEC16A SMO IRS2 MMP11 MMP14 | 1.78e-06 | 1208 | 124 | 22 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-09 | 193 | 135 | 9 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-09 | 193 | 135 | 9 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.57e-09 | 197 | 135 | 9 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | GOLGA8Q GOLGA8N GOLGA8IP NFATC2 KIR2DL1 KIR2DL2 KIR3DL1 GOLGA8O UTRN | 1.04e-08 | 199 | 135 | 9 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | GOLGA8Q GOLGA8N GOLGA8IP NFATC2 KIR2DL1 KIR2DL2 KIR3DL1 GOLGA8O UTRN | 1.04e-08 | 199 | 135 | 9 | 5f914962e2572b0c6372465b81b7496fa663d93c |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-NK|ICU-SEP / Disease, Lineage and Cell Type | MMP23B GOLGA8M NFATC2 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2 | 1.38e-07 | 193 | 135 | 8 | f110f86db305e41639087f5b1a2dff103c07adf0 |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.74e-07 | 199 | 135 | 8 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID-19_Moderate-NK|World / disease group, cell group and cell class | 1.74e-07 | 199 | 135 | 8 | c41b67b760831c7d5e19fabcc932a056dc560f93 | |
| ToppCell | COVID-19_Moderate-NK|COVID-19_Moderate / disease group, cell group and cell class | 1.74e-07 | 199 | 135 | 8 | e0e83ba511957be9ad3413460dcb6b7d7b65dd18 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.74e-07 | 199 | 135 | 8 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-NK|ICU-SEP / Disease, condition lineage and cell class | MMP23B GOLGA8M NFATC2 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2 | 1.81e-07 | 200 | 135 | 8 | 6813fa6d24950fac22e2b5bb26b64f79214163b6 |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 7.04e-07 | 164 | 135 | 7 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.09e-06 | 175 | 135 | 7 | 8fb8c4b9e2d9b7d737f59cd9bd3dc2bca5a8dfc4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-06 | 185 | 135 | 7 | 872720275789d249c9859de825a923803d458875 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-mature_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.02e-06 | 192 | 135 | 7 | e48bbcb97c113f323ad4db96bd10d593b9206923 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-06 | 192 | 135 | 7 | f88aba74d6e8c594c32fe2bc095b5da28b4b28e9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-06 | 192 | 135 | 7 | 41a8326cd5bc19ad5041068501bab4c72399222e | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-06 | 193 | 135 | 7 | 0a665531d581d4e3941e29d3f95569da8f166447 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-06 | 193 | 135 | 7 | 24ce1f37cca655415410d2403a52d1ebb3332280 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.16e-06 | 194 | 135 | 7 | 5a859885c0f9b8554b0d203e371c70928ad4418f | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 2.16e-06 | 194 | 135 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | 10x5'-blood-Lymphocytic_NK-NK_CD16|blood / Manually curated celltypes from each tissue | 2.16e-06 | 194 | 135 | 7 | c34a32f1cfe3e597cb0f91ba5bdd3e114e9f3d2e | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-06 | 194 | 135 | 7 | 2d0cff9dc538a14518741e2a96d9d78442c81a72 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.16e-06 | 194 | 135 | 7 | 7d35ac70ba966eb1fee4197f7de6d6116326a442 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue | 2.16e-06 | 194 | 135 | 7 | 7773501e076d470158dbc1d7f10c67152b326eb7 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.16e-06 | 194 | 135 | 7 | ae5357e2a276473cde1fc8c43acaf9f69da35fd7 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 2.16e-06 | 194 | 135 | 7 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.16e-06 | 194 | 135 | 7 | 3a0b8b5d0354c43da57bb951cd8ba878363c3de5 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue | 2.24e-06 | 195 | 135 | 7 | e91e7f89163c615b706f3297b641b1e4c966f5e6 | |
| ToppCell | 10x5'-blood-Lymphocytic_NK|blood / Manually curated celltypes from each tissue | 2.24e-06 | 195 | 135 | 7 | c1db871e8e8e8b8d6a5798bc43eaf54e102b75eb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.24e-06 | 195 | 135 | 7 | 98b02beafe1d418442e41f85cbf0c7b194fe5957 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.24e-06 | 195 | 135 | 7 | 9ecae6c26a0d0607d101ccf1c38f0b23c5a256a8 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue | 2.24e-06 | 195 | 135 | 7 | a5a10ef9254c266316e5591bec19e159cc3caead | |
| ToppCell | BL-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.31e-06 | 196 | 135 | 7 | cfbeaabbeeb197f0cf8240a752d1f2995d59d7b7 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.31e-06 | 196 | 135 | 7 | d3bd8fab010e76024d7e06aba0ea5df3394f411f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.31e-06 | 196 | 135 | 7 | 9b3848dd4256cd6d9a21ef6bfdbd0cb7c0030005 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.31e-06 | 196 | 135 | 7 | 78b28b263deaa43590b38597186222c6447ad25f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.31e-06 | 196 | 135 | 7 | 77da6b1bcab45d376eb0368f540e0ed24ce98b42 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.31e-06 | 196 | 135 | 7 | 3e78e307c9c991c1aadc85c61d401431cf75eaec | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.31e-06 | 196 | 135 | 7 | f0566f2ef96584ed6d9247b149218376fb509915 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue | 2.31e-06 | 196 | 135 | 7 | a3b077e82b1550eb328c84b567b60179001f9a77 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue | 2.31e-06 | 196 | 135 | 7 | 1868ad537b7f04cdad0a0c8282aadbc4f257a722 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.39e-06 | 197 | 135 | 7 | 9993fdea353abeafc009ac87439ad25cedf8f1f6 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.39e-06 | 197 | 135 | 7 | 300849a922722adcbc068593fc5cc0bef936d9cb | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.39e-06 | 197 | 135 | 7 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.39e-06 | 197 | 135 | 7 | a8b41fffa4e86f2766423392951ff320e821a19a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.39e-06 | 197 | 135 | 7 | bc37b8919f98dc18c2200834405f06823d965d78 | |
| ToppCell | severe-Lymphocytic-NK_cells|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.39e-06 | 197 | 135 | 7 | 8bf88b10d49ac499e7d0ba5b7023909e1fd7b29a | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.39e-06 | 197 | 135 | 7 | a97c4a9eb89260b0b5745834ccef9d558d857f93 | |
| ToppCell | severe_COVID-19-NK|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.47e-06 | 198 | 135 | 7 | 7f51e37516f717e424190e6584f1c74d357e2da4 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.47e-06 | 198 | 135 | 7 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | mild-Lymphocytic-NK_cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.47e-06 | 198 | 135 | 7 | dce3c008757786aa6bd4a869456b76b4cbbb1d5b | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|tumor_Lung / Location, Cell class and cell subclass | 2.47e-06 | 198 | 135 | 7 | 31f9181dab689aabe9c6182c2ef7de65ba3f0ff6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.47e-06 | 198 | 135 | 7 | 1a189b2b213099505c5d871fb8aedd55a97d44e0 | |
| ToppCell | severe_COVID-19-NK|World / disease group, cell group and cell class (v2) | 2.47e-06 | 198 | 135 | 7 | 36b1370ef68c4bbe0268933a6ef5e6022d992bdf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.56e-06 | 199 | 135 | 7 | b03539908131308d7bf5036e78c4c840a6a79a17 | |
| ToppCell | COVID-19_Severe-NK_activated|COVID-19_Severe / disease group, cell group and cell class | 2.56e-06 | 199 | 135 | 7 | bda28d975f4017ec5bded1d3c72310eabc5aac07 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.56e-06 | 199 | 135 | 7 | 4820f5bcd7bc34c2ebf6a3422cc8eb383a3b5a4e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.56e-06 | 199 | 135 | 7 | eb05ccae5187e4701bbbe6d714a6d2808fbcf306 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.56e-06 | 199 | 135 | 7 | 10c8729b779073c3bf808e85958d59147f0be5c5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.56e-06 | 199 | 135 | 7 | 867fd292f3879982422e840e087bfdb3b21a8715 | |
| ToppCell | Sepsis-URO|Sepsis / Disease, condition lineage and cell class | 2.56e-06 | 199 | 135 | 7 | 8e6dac82d1d0e759cd567f9c95b70cb4801d7caf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.56e-06 | 199 | 135 | 7 | 7d071c88a003babf6dbdb84dde561fc03c92f375 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 2.56e-06 | 199 | 135 | 7 | 9f6b6731186ef399f952a75879eba66fd8ed3494 | |
| ToppCell | Control-Lymphoid_T/NK-NK|Control / Disease group, lineage and cell class | 2.56e-06 | 199 | 135 | 7 | 94b2693a8378b9b2c58c6aebb2c6658d75b2e3de | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK|Control / Disease, condition lineage and cell class | 2.64e-06 | 200 | 135 | 7 | c64c27dbf4df42ca2ad2bd94b50fab87b4050ef3 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-NK|Leuk-UTI / Disease, condition lineage and cell class | 2.64e-06 | 200 | 135 | 7 | bb37fed4872e71f413ae7c4aa12586fa31075334 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.64e-06 | 200 | 135 | 7 | 94bd00fb6ff0dcb668eb36ec2085f1c3128855b6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-06 | 150 | 135 | 6 | 7a9d6a7ff8000e9a061e1b586e4c258cc91a2a09 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-06 | 150 | 135 | 6 | e5b843cb2bc847f6cab4cbec0a2a6a72fac50fee | |
| ToppCell | facs-Spleen-nan-24m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.20e-06 | 156 | 135 | 6 | 034d4359359a44c205c6931f38a375271ac2752b | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.20e-06 | 156 | 135 | 6 | 2a4dac4100c0339aad4905b8eaca6e8fe806718b | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.20e-06 | 156 | 135 | 6 | 21267718d3a3dc19988663b6846aed8bb3eae836 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Lung / Manually curated celltypes from each tissue | 8.20e-06 | 156 | 135 | 6 | 0ea6ca3f38109151a2a4fdf63a4f009929cdcc40 | |
| ToppCell | facs-Brain_Myeloid-Striatum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.50e-06 | 157 | 135 | 6 | 9d4308312301cb922f156a7b6aededc9e1c62807 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.82e-06 | 161 | 135 | 6 | 3f3a2148c8d65e6a06f8d8116a3aa58dda17d618 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-05 | 167 | 135 | 6 | 805129f887078340b260aa136b0ba19f2bd6ea03 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-05 | 167 | 135 | 6 | 31cf8bf2eb523f6e7e319620648ff37fc09e2601 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-05 | 167 | 135 | 6 | 3acb18428d1d33ad430c2fd031b1a91baee3c01d | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.25e-05 | 168 | 135 | 6 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.25e-05 | 168 | 135 | 6 | b4bb03efb601a61465260f93896c56861c588bef | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.25e-05 | 168 | 135 | 6 | 240ea32b64d86f9216785010d6b237d9adf052c9 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-05 | 169 | 135 | 6 | e7470a5b060881b2a8ce2ab04b0788396aa13889 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-05 | 169 | 135 | 6 | a3234904d7ff8f451ca894e93badd61d75e3cd2a | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 170 | 135 | 6 | dbd6c9c7be824a1ff1b31af791064127cafbd194 | |
| ToppCell | NS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.38e-05 | 171 | 135 | 6 | adda76991d9b150bb8ccf3989b7cbbf41843cf0b | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-05 | 172 | 135 | 6 | de4961f4037c439d3e0ec706a257b0ec17f4d5be | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.43e-05 | 172 | 135 | 6 | e3a8891694343b6b01e80a200ae338d24797e417 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-05 | 177 | 135 | 6 | 14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6 | |
| ToppCell | myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell|myeloid / Lineage, cell class and subclass | 1.74e-05 | 178 | 135 | 6 | f75591988bbbeba073b66329a3437cb9b02f7648 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 179 | 135 | 6 | dfd9d29281510d32f1a2e8336d2e58ef496cfd1d | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 182 | 135 | 6 | f4b74c2756989812abe4e7055ec8918f69d56025 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 2.09e-05 | 184 | 135 | 6 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-05 | 186 | 135 | 6 | 35c88cc4eb388811fcac4323b549e5897fa8dc27 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.22e-05 | 186 | 135 | 6 | 1590fe72badffc79f1d390deb3207116ac2281bb | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-mature_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.22e-05 | 186 | 135 | 6 | 165d02be3b3eaeb8784a2b0b2020928b21a19bc7 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-NK_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.22e-05 | 186 | 135 | 6 | e37e317e9770e35cb41137f51868d8b20ecd21d8 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.22e-05 | 186 | 135 | 6 | e84a0ba599935ca5e7af48e0fb0500e7ed195d55 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-05 | 186 | 135 | 6 | d998c5b00083cf2a7cd5341a98b7374b4de73c63 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.36e-05 | 188 | 135 | 6 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| Computational | MMPs. | 5.90e-11 | 21 | 74 | 7 | MODULE_562 | |
| Computational | Genes in the cancer module 211. | 6.03e-09 | 11 | 74 | 5 | MODULE_211 | |
| Computational | Genes in the cancer module 210. | 2.89e-08 | 28 | 74 | 6 | MODULE_210 | |
| Computational | Metal ion (zinc) binding. | 5.71e-07 | 45 | 74 | 6 | MODULE_280 | |
| Computational | Genes in the cancer module 107. | 1.07e-06 | 79 | 74 | 7 | MODULE_107 | |
| Computational | Genes in the cancer module 172. | 4.01e-06 | 96 | 74 | 7 | MODULE_172 | |
| Computational | Neighborhood of IL2RB | 1.48e-05 | 46 | 74 | 5 | GNF2_IL2RB | |
| Computational | Genes in the cancer module 371. | 2.76e-05 | 26 | 74 | 4 | MODULE_371 | |
| Computational | Metal / Ca ion binding. | 2.98e-04 | 133 | 74 | 6 | MODULE_324 | |
| Computational | Catabolic peptidases. | 3.57e-04 | 89 | 74 | 5 | MODULE_209 | |
| Drug | malolactomycin D | 2.05e-15 | 32 | 134 | 10 | CID006449115 | |
| Drug | AC1L1GXT | MMP23B PER1 MMP25 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 5.90e-13 | 74 | 134 | 11 | CID000003890 |
| Drug | CGS 27023A | 3.07e-12 | 9 | 134 | 6 | ctd:C097658 | |
| Drug | AC1L1DD6 | MMP23B MSTN MMP25 VCAN ADAM17 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 NOS1AP | 3.11e-12 | 179 | 134 | 14 | CID000002299 |
| Drug | diacerein | 3.48e-12 | 63 | 134 | 10 | CID000026248 | |
| Drug | DA-125 | 1.25e-10 | 26 | 134 | 7 | CID000114758 | |
| Drug | Marimastat | 3.62e-10 | 8 | 134 | 5 | DB00786 | |
| Drug | Ro 32-3555 | 3.62e-10 | 8 | 134 | 5 | CID000193987 | |
| Drug | mercuric acetate | 3.80e-10 | 30 | 134 | 7 | CID000015337 | |
| Drug | pirfenidone | MMP23B MSTN MMP25 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 5.91e-10 | 138 | 134 | 11 | CID000040632 |
| Drug | MMI270 | 6.50e-10 | 18 | 134 | 6 | CID000446504 | |
| Drug | isoflavone | ADAMTS2 MMP23B MMP25 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 2.04e-09 | 155 | 134 | 11 | CID000072304 |
| Drug | 4-aminophenyl | 3.02e-09 | 62 | 134 | 8 | CID000181201 | |
| Drug | carvedilol | MMP23B MSTN MMP25 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 3.05e-09 | 161 | 134 | 11 | CID000002585 |
| Drug | titanium | MMP23B MMP25 SHANK2 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 5.40e-09 | 170 | 134 | 11 | CID000023963 |
| Drug | beta-sulfone 7f | 5.71e-09 | 5 | 134 | 4 | CID011526076 | |
| Drug | alpha-sulfone 27e | 5.71e-09 | 5 | 134 | 4 | CID011719408 | |
| Drug | CTS-1027 | 5.71e-09 | 5 | 134 | 4 | CID003342298 | |
| Drug | SC-276 | 5.71e-09 | 5 | 134 | 4 | CID009802768 | |
| Drug | alpha-sulfone 35g | 5.71e-09 | 5 | 134 | 4 | CID011705502 | |
| Drug | beta-sulfone 7d | 5.71e-09 | 5 | 134 | 4 | CID011548264 | |
| Drug | alpha-sulfone 27g | 5.71e-09 | 5 | 134 | 4 | CID011561491 | |
| Drug | beta-sulfone 7e | 5.71e-09 | 5 | 134 | 4 | CID011641261 | |
| Drug | beta-sulfone 7b | 5.71e-09 | 5 | 134 | 4 | CID009867183 | |
| Drug | alpha-sulfone 27d | 5.71e-09 | 5 | 134 | 4 | CID011532911 | |
| Drug | alpha-sulfone 27b | 5.71e-09 | 5 | 134 | 4 | CID011697282 | |
| Drug | beta-sulfone 7c | 5.71e-09 | 5 | 134 | 4 | CID011613649 | |
| Drug | marimastat | 6.41e-09 | 68 | 134 | 8 | CID000119031 | |
| Drug | FN-439 | 8.12e-09 | 13 | 134 | 5 | CID000004648 | |
| Drug | dioxane | HDAC4 MMP23B GATA1 TFE3 MMP25 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 1.08e-08 | 278 | 134 | 13 | CID000031275 |
| Drug | Ageladine A | 1.26e-08 | 14 | 134 | 5 | ctd:C482289 | |
| Drug | A0395 | 1.41e-08 | 75 | 134 | 8 | CID009906466 | |
| Drug | AC1NSU5S | 1.41e-08 | 75 | 134 | 8 | CID005316299 | |
| Drug | Aa1 | KCNJ4 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 | 3.17e-08 | 83 | 134 | 8 | CID009549188 |
| Drug | AC1L1G2K | 3.49e-08 | 84 | 134 | 8 | CID000003498 | |
| Drug | prinomastat | 3.61e-08 | 33 | 134 | 6 | CID000466151 | |
| Drug | AC1L9M3B | 6.99e-08 | 61 | 134 | 7 | CID000448562 | |
| Drug | gluconate | MMP23B MMP25 JAK3 FSHR MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 1.37e-07 | 287 | 134 | 12 | CID000000604 |
| Drug | alpha-sulfone 21 | 1.99e-07 | 3 | 134 | 3 | CID009822926 | |
| Drug | pseudococaine | SALL3 MMP23B PER1 MMP25 SCN10A DLG4 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 GPSM1 | 2.57e-07 | 570 | 134 | 16 | CID000002826 |
| Drug | Matrix Metalloproteinase Inhibitors | 3.67e-07 | 11 | 134 | 4 | ctd:D061965 | |
| Drug | benzoyl isothiocyanate | 3.67e-07 | 11 | 134 | 4 | CID000068284 | |
| Drug | Pro-leu-gly | 3.90e-07 | 26 | 134 | 5 | CID000169533 | |
| Drug | AC1L1HMM | MMP23B PPID NUBP2 MMP25 NCOR1 NFATC2 MMP1 MMP3 PLEC MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 4.02e-07 | 516 | 134 | 15 | CID000004196 |
| Drug | 1,10-phenanthroline | MMP23B MMP25 ADAM17 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 5.41e-07 | 267 | 134 | 11 | CID000001318 |
| Drug | methylprednisolone acetate | 5.47e-07 | 12 | 134 | 4 | ctd:C000873 | |
| Drug | formosanin C | 7.87e-07 | 13 | 134 | 4 | ctd:C067584 | |
| Drug | carbamoylphosphonic acid | 7.94e-07 | 4 | 134 | 3 | CID013879809 | |
| Drug | 3-hydroxypicolinic acid | 7.94e-07 | 4 | 134 | 3 | ctd:C049246 | |
| Drug | alpha-sulfone 35h | 7.94e-07 | 4 | 134 | 3 | CID011684849 | |
| Drug | alpha-sulfone 35a | 7.94e-07 | 4 | 134 | 3 | CID011633617 | |
| Drug | alpha-sulfone 35c | 7.94e-07 | 4 | 134 | 3 | CID011533203 | |
| Drug | alpha-sulfone 35d | 7.94e-07 | 4 | 134 | 3 | CID009954521 | |
| Drug | oxidized glutathione | 9.88e-07 | 227 | 134 | 10 | CID000000975 | |
| Drug | D3273 | 1.40e-06 | 94 | 134 | 7 | CID005464587 | |
| Drug | noradrealine | MMP23B PER1 HBP1 MSTN MMP25 SHANK2 MMP1 MMP3 MMP8 MMP9 BSN MMP11 MMP13 MMP14 MMP15 | 1.56e-06 | 575 | 134 | 15 | CID000000951 |
| Drug | quinacrine | 1.83e-06 | 243 | 134 | 10 | CID000000237 | |
| Drug | enantio-PAF-C16 | 1.90e-06 | 244 | 134 | 10 | CID000002499 | |
| Drug | MMP-3 inhibitor | 1.98e-06 | 5 | 134 | 3 | CID010549329 | |
| Drug | PD-0200347 | 1.98e-06 | 5 | 134 | 3 | ctd:C497431 | |
| Drug | prinomastat | 1.98e-06 | 5 | 134 | 3 | ctd:C113282 | |
| Drug | 1-(3',5'-dihydroxyphenoxy)-7-(2'',4'',6''-trihydroxyphenoxy)-2,4,9-trihydroxydibenzo-1,4,-dioxin | 1.98e-06 | 5 | 134 | 3 | ctd:C540360 | |
| Drug | CGS 25966 | 1.98e-06 | 5 | 134 | 3 | CID009821883 | |
| Drug | Androgens | 2.10e-06 | 64 | 134 | 6 | ctd:D000728 | |
| Drug | peroxynitrite | MMP23B MSTN MMP25 GLI3 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 2.20e-06 | 373 | 134 | 12 | CID000104806 |
| Drug | losartan | MMP23B MSTN MMP25 VCAN MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 2.52e-06 | 378 | 134 | 12 | CID000003961 |
| Drug | compound 22 | 2.81e-06 | 38 | 134 | 5 | CID000205101 | |
| Drug | AC1NRBJE | 3.36e-06 | 152 | 134 | 8 | CID005288446 | |
| Drug | latanoprost acid | 3.65e-06 | 40 | 134 | 5 | CID006441636 | |
| Drug | hydroxylysine | 3.78e-06 | 109 | 134 | 7 | CID000001029 | |
| Drug | 4-aminoproline | 3.94e-06 | 6 | 134 | 3 | CID000124558 | |
| Drug | varespladib methyl | 3.94e-06 | 6 | 134 | 3 | ctd:C545088 | |
| Drug | 2-Amino-5-mercapto-1,3,4-thiadiazole | 3.94e-06 | 6 | 134 | 3 | CID002723847 | |
| Drug | Hydroxamate 12 | 3.94e-06 | 6 | 134 | 3 | CID010594000 | |
| Drug | dieckol | 3.94e-06 | 6 | 134 | 3 | ctd:C503840 | |
| Drug | Pz-plgpa | 4.15e-06 | 19 | 134 | 4 | CID000152296 | |
| Drug | aldosterone | MMP23B PER1 MMP25 NCOR1 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 4.17e-06 | 397 | 134 | 12 | CID000005839 |
| Drug | N-methylmesoporphyrin | 4.68e-06 | 42 | 134 | 5 | CID000444708 | |
| Drug | phosphocitrate | 5.17e-06 | 20 | 134 | 4 | CID000123745 | |
| Drug | Pz-peptide | 5.17e-06 | 20 | 134 | 4 | CID000161208 | |
| Drug | metrizamide | 5.17e-06 | 20 | 134 | 4 | CID000035734 | |
| Drug | D-Au | 6.25e-06 | 77 | 134 | 6 | CID000277822 | |
| Drug | Ab-9 | 6.35e-06 | 21 | 134 | 4 | CID006540280 | |
| Drug | 1zd2 | 6.63e-06 | 45 | 134 | 5 | CID004149241 | |
| Drug | tetracycline CMT-8 | 6.86e-06 | 7 | 134 | 3 | ctd:C117153 | |
| Drug | CGS 27023A Analog 51 | 6.86e-06 | 7 | 134 | 3 | CID010594938 | |
| Drug | glycylvaline | 7.40e-06 | 46 | 134 | 5 | CID000097417 | |
| Drug | AC1ND30P | 7.73e-06 | 22 | 134 | 4 | CID004568793 | |
| Drug | Cbz-gplgp | 7.73e-06 | 22 | 134 | 4 | CID000193354 | |
| Drug | 1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea | 9.16e-06 | 48 | 134 | 5 | ctd:C581572 | |
| Drug | Sc 40827 | 1.09e-05 | 8 | 134 | 3 | CID000127918 | |
| Drug | Phospholipase A2 Inhibitors | 1.09e-05 | 8 | 134 | 3 | ctd:D064801 | |
| Drug | dieckol | 1.09e-05 | 8 | 134 | 3 | CID003008868 | |
| Drug | dithizone | 1.11e-05 | 24 | 134 | 4 | CID000657262 | |
| Drug | glycoluril | 1.50e-05 | 53 | 134 | 5 | CID000062347 | |
| Drug | AC1L1B55 | MMP23B HBP1 MSTN MMP25 MMP1 MMP3 MMP8 MMP9 MMP11 MMP13 MMP14 MMP15 | 1.60e-05 | 454 | 134 | 12 | CID000001287 |
| Drug | thiazepine | 1.63e-05 | 9 | 134 | 3 | CID012444276 | |
| Drug | (1R,2R,4S,5R)-6-methylolcyclohexane-1,2,3,4,5-pentol | 1.63e-05 | 9 | 134 | 3 | CID011321479 | |
| Drug | NSC101638 | 1.63e-05 | 9 | 134 | 3 | CID000265520 | |
| Drug | YM 529 | 1.63e-05 | 9 | 134 | 3 | ctd:C087958 | |
| Disease | thoracic aortic aneurysm (is_marker_for) | 2.97e-07 | 14 | 125 | 4 | DOID:14004 (is_marker_for) | |
| Disease | osteoarthritis (is_marker_for) | 3.69e-07 | 35 | 125 | 5 | DOID:8398 (is_marker_for) | |
| Disease | congestive heart failure (biomarker_via_orthology) | 3.79e-07 | 107 | 125 | 7 | DOID:6000 (biomarker_via_orthology) | |
| Disease | killer cell immunoglobulin-like receptor 2DS2 measurement | 4.04e-07 | 15 | 125 | 4 | EFO_0801746 | |
| Disease | anodontia (is_implicated_in) | 7.38e-07 | 5 | 125 | 3 | DOID:13714 (is_implicated_in) | |
| Disease | gastric ulcer (biomarker_via_orthology) | 1.74e-06 | 21 | 125 | 4 | DOID:10808 (biomarker_via_orthology) | |
| Disease | abdominal aortic aneurysm (is_marker_for) | 8.71e-06 | 10 | 125 | 3 | DOID:7693 (is_marker_for) | |
| Disease | arteriosclerosis (is_implicated_in) | 8.84e-06 | 31 | 125 | 4 | DOID:2349 (is_implicated_in) | |
| Disease | interstitial collagenase measurement | 1.19e-05 | 11 | 125 | 3 | EFO_0008193 | |
| Disease | killer cell immunoglobulin-like receptor 2DL4 measurement | 1.59e-05 | 12 | 125 | 3 | EFO_0008197 | |
| Disease | Metaphyseal anadysplasia | 1.78e-05 | 2 | 125 | 2 | C0432226 | |
| Disease | varicose veins (is_implicated_in) | 1.78e-05 | 2 | 125 | 2 | DOID:799 (is_implicated_in) | |
| Disease | skin melanoma (is_implicated_in) | 2.61e-05 | 14 | 125 | 3 | DOID:8923 (is_implicated_in) | |
| Disease | thrombosis (is_implicated_in) | 3.25e-05 | 15 | 125 | 3 | DOID:0060903 (is_implicated_in) | |
| Disease | serum albumin measurement | MOGAT2 TRPS1 HBP1 IP6K1 SVEP1 SLC45A4 CLTB DLG4 PLEC BSN QSOX2 | 4.55e-05 | 592 | 125 | 11 | EFO_0004535 |
| Disease | immunoglobulin light chain amyloidosis (is_marker_for) | 5.33e-05 | 3 | 125 | 2 | DOID:0080933 (is_marker_for) | |
| Disease | level of killer cell immunoglobulin-like receptor 2DS2 in blood serum | 5.33e-05 | 3 | 125 | 2 | OBA_2042107 | |
| Disease | meningococcal meningitis (biomarker_via_orthology) | 5.33e-05 | 3 | 125 | 2 | DOID:0080176 (biomarker_via_orthology) | |
| Disease | Takayasu's arteritis (is_marker_for) | 5.33e-05 | 3 | 125 | 2 | DOID:2508 (is_marker_for) | |
| Disease | conjunctivochalasis (is_marker_for) | 5.33e-05 | 3 | 125 | 2 | DOID:4250 (is_marker_for) | |
| Disease | Acute Megakaryocytic Leukemias | 5.33e-05 | 3 | 125 | 2 | C0023462 | |
| Disease | Craniofacial Abnormalities | 5.54e-05 | 156 | 125 | 6 | C0376634 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 5.61e-05 | 49 | 125 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | esophagus adenocarcinoma (is_implicated_in) | 9.33e-05 | 21 | 125 | 3 | DOID:4914 (is_implicated_in) | |
| Disease | thoracic aortic aneurysm (biomarker_via_orthology) | 1.06e-04 | 4 | 125 | 2 | DOID:14004 (biomarker_via_orthology) | |
| Disease | psoriatic arthritis (is_marker_for) | 1.06e-04 | 4 | 125 | 2 | DOID:9008 (is_marker_for) | |
| Disease | carotid artery disease (is_implicated_in) | 1.08e-04 | 22 | 125 | 3 | DOID:3407 (is_implicated_in) | |
| Disease | Liver Cirrhosis, Experimental | ERN1 PPP1R3B TMEM43 SULT1E1 ADAM17 RAB40B MMP1 MMP8 MMP9 MMP13 MMP15 LRRFIP1 | 1.15e-04 | 774 | 125 | 12 | C0023893 |
| Disease | Sjogren's syndrome (is_marker_for) | 1.41e-04 | 24 | 125 | 3 | DOID:12894 (is_marker_for) | |
| Disease | rheumatoid arthritis (is_marker_for) | 2.14e-04 | 69 | 125 | 4 | DOID:7148 (is_marker_for) | |
| Disease | renal cell carcinoma (is_implicated_in) | 2.14e-04 | 69 | 125 | 4 | DOID:4450 (is_implicated_in) | |
| Disease | primary biliary cholangitis (biomarker_via_orthology) | 2.25e-04 | 28 | 125 | 3 | DOID:12236 (biomarker_via_orthology) | |
| Disease | amyotrophic lateral sclerosis (is_marker_for) | 2.50e-04 | 29 | 125 | 3 | DOID:332 (is_marker_for) | |
| Disease | allergic contact dermatitis (biomarker_via_orthology) | 2.64e-04 | 6 | 125 | 2 | DOID:3042 (biomarker_via_orthology) | |
| Disease | carotid stenosis (is_implicated_in) | 2.64e-04 | 6 | 125 | 2 | DOID:13001 (is_implicated_in) | |
| Disease | Down syndrome (is_implicated_in) | 2.64e-04 | 6 | 125 | 2 | DOID:14250 (is_implicated_in) | |
| Disease | cortical thickness | PRR23A ADAMTS2 PPP1R3B TRPS1 LAMC3 PPID PCDH17 SLC45A4 ZNF469 GLI3 VCAN FSHR SSH2 PLEC | 2.72e-04 | 1113 | 125 | 14 | EFO_0004840 |
| Disease | Disproportionate short stature | 3.27e-04 | 77 | 125 | 4 | C0878659 | |
| Disease | degenerative disc disease (implicated_via_orthology) | 3.69e-04 | 7 | 125 | 2 | DOID:90 (implicated_via_orthology) | |
| Disease | Chronic Obstructive Airway Disease | 3.69e-04 | 33 | 125 | 3 | C0024117 | |
| Disease | Chronic Airflow Obstruction | 3.69e-04 | 33 | 125 | 3 | C1527303 | |
| Disease | breast cancer (is_implicated_in) | 4.56e-04 | 150 | 125 | 5 | DOID:1612 (is_implicated_in) | |
| Disease | matrix metalloproteinase 7 measurement | 4.90e-04 | 8 | 125 | 2 | EFO_0010591 | |
| Disease | crescentic glomerulonephritis (biomarker_via_orthology) | 4.90e-04 | 8 | 125 | 2 | DOID:13139 (biomarker_via_orthology) | |
| Disease | cognitive disorder (biomarker_via_orthology) | 4.90e-04 | 8 | 125 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | Ehlers-Danlos syndrome | 4.90e-04 | 8 | 125 | 2 | cv:C0013720 | |
| Disease | benign neoplasm (implicated_via_orthology) | 4.90e-04 | 8 | 125 | 2 | DOID:0060072 (implicated_via_orthology) | |
| Disease | influenza A (H1N1) | 5.21e-04 | 87 | 125 | 4 | EFO_1001488 | |
| Disease | Non-Small Cell Lung Carcinoma | 5.45e-04 | 156 | 125 | 5 | C0007131 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 6.29e-04 | 9 | 125 | 2 | DOID:13359 (is_implicated_in) | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 6.29e-04 | 9 | 125 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | acquired immunodeficiency syndrome (is_implicated_in) | 6.29e-04 | 9 | 125 | 2 | DOID:635 (is_implicated_in) | |
| Disease | Glaucoma | 6.29e-04 | 9 | 125 | 2 | C0017601 | |
| Disease | Aortic Aneurysm, Abdominal | 7.84e-04 | 10 | 125 | 2 | C0162871 | |
| Disease | glomerulosclerosis (biomarker_via_orthology) | 7.84e-04 | 10 | 125 | 2 | DOID:0050851 (biomarker_via_orthology) | |
| Disease | myocardial infarction (is_implicated_in) | 8.47e-04 | 99 | 125 | 4 | DOID:5844 (is_implicated_in) | |
| Disease | glomerulosclerosis (implicated_via_orthology) | 9.55e-04 | 11 | 125 | 2 | DOID:0050851 (implicated_via_orthology) | |
| Disease | granulosa cell tumor (is_marker_for) | 9.55e-04 | 11 | 125 | 2 | DOID:2999 (is_marker_for) | |
| Disease | T-cell acute lymphoblastic leukemia (is_implicated_in) | 9.55e-04 | 11 | 125 | 2 | DOID:5603 (is_implicated_in) | |
| Disease | thoracic aortic aneurysm (is_implicated_in) | 9.55e-04 | 11 | 125 | 2 | DOID:14004 (is_implicated_in) | |
| Disease | Marfan Syndrome | 9.55e-04 | 11 | 125 | 2 | C0024796 | |
| Disease | pulmonary emphysema (is_implicated_in) | 9.55e-04 | 11 | 125 | 2 | DOID:9675 (is_implicated_in) | |
| Disease | degenerative disc disease (biomarker_via_orthology) | 9.55e-04 | 11 | 125 | 2 | DOID:90 (biomarker_via_orthology) | |
| Disease | Gastrointestinal Stromal Sarcoma | 1.05e-03 | 47 | 125 | 3 | C3179349 | |
| Disease | alcohol dependence | 1.12e-03 | 183 | 125 | 5 | MONDO_0007079 | |
| Disease | urinary bladder cancer (is_marker_for) | 1.13e-03 | 107 | 125 | 4 | DOID:11054 (is_marker_for) | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 1.14e-03 | 12 | 125 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | intracranial aneurysm (is_implicated_in) | 1.14e-03 | 12 | 125 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | abdominal aortic aneurysm (is_implicated_in) | 1.14e-03 | 12 | 125 | 2 | DOID:7693 (is_implicated_in) | |
| Disease | Neoplasm Invasiveness | 1.14e-03 | 184 | 125 | 5 | C0027626 | |
| Disease | Gastrointestinal Stromal Tumors | 1.26e-03 | 50 | 125 | 3 | C0238198 | |
| Disease | liver cirrhosis (implicated_via_orthology) | 1.35e-03 | 13 | 125 | 2 | DOID:5082 (implicated_via_orthology) | |
| Disease | hypertension (is_marker_for) | 1.49e-03 | 53 | 125 | 3 | DOID:10763 (is_marker_for) | |
| Disease | abdominal aortic aneurysm (biomarker_via_orthology) | 1.57e-03 | 14 | 125 | 2 | DOID:7693 (biomarker_via_orthology) | |
| Disease | atrial fibrillation (is_implicated_in) | 1.57e-03 | 14 | 125 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | autosomal dominant polycystic kidney disease (is_marker_for) | 1.57e-03 | 14 | 125 | 2 | DOID:898 (is_marker_for) | |
| Disease | intracranial aneurysm (is_marker_for) | 1.57e-03 | 14 | 125 | 2 | DOID:10941 (is_marker_for) | |
| Disease | T wave morphology measurement | 1.57e-03 | 14 | 125 | 2 | EFO_0008398 | |
| Disease | pulmonary hypertension (implicated_via_orthology) | 1.57e-03 | 54 | 125 | 3 | DOID:6432 (implicated_via_orthology) | |
| Disease | matrix metalloproteinase 1 measurement | 1.80e-03 | 15 | 125 | 2 | EFO_0010588 | |
| Disease | neuroimaging measurement | PRR23A SZT2 TRPS1 NCOR1 ZNF469 GLI3 VCAN FSHR DLG2 SSH2 PLEC QSOX2 | 1.98e-03 | 1069 | 125 | 12 | EFO_0004346 |
| Disease | Romano-Ward Syndrome | 2.05e-03 | 16 | 125 | 2 | C0035828 | |
| Disease | cholesteatoma of middle ear (is_marker_for) | 2.05e-03 | 16 | 125 | 2 | DOID:10964 (is_marker_for) | |
| Disease | ocular hypertension (biomarker_via_orthology) | 2.32e-03 | 17 | 125 | 2 | DOID:9282 (biomarker_via_orthology) | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 2.32e-03 | 17 | 125 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | lateral occipital cortex volume measurement | 2.32e-03 | 17 | 125 | 2 | EFO_0010311 | |
| Disease | transitional cell carcinoma (is_marker_for) | 2.45e-03 | 63 | 125 | 3 | DOID:2671 (is_marker_for) | |
| Disease | cholangiocarcinoma (is_marker_for) | 2.56e-03 | 64 | 125 | 3 | DOID:4947 (is_marker_for) | |
| Disease | carcinoma (implicated_via_orthology) | 2.56e-03 | 64 | 125 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | matrix metalloproteinase 12 measurement | 2.61e-03 | 18 | 125 | 2 | EFO_0010590 | |
| Disease | Oral Submucous Fibrosis | 2.61e-03 | 18 | 125 | 2 | C0029172 | |
| Disease | myocardial infarction (implicated_via_orthology) | 2.80e-03 | 66 | 125 | 3 | DOID:5844 (implicated_via_orthology) | |
| Disease | Chronic myeloproliferative disorder | 2.90e-03 | 19 | 125 | 2 | C1292778 | |
| Disease | Intellectual Disability | 3.01e-03 | 447 | 125 | 7 | C3714756 | |
| Disease | Bladder Neoplasm | 3.02e-03 | 140 | 125 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 3.10e-03 | 141 | 125 | 4 | C0005684 | |
| Disease | glaucoma (is_marker_for) | 3.22e-03 | 20 | 125 | 2 | DOID:1686 (is_marker_for) | |
| Disease | osteoarthritis (biomarker_via_orthology) | 3.55e-03 | 21 | 125 | 2 | DOID:8398 (biomarker_via_orthology) | |
| Disease | periodontitis (biomarker_via_orthology) | 3.55e-03 | 21 | 125 | 2 | DOID:824 (biomarker_via_orthology) | |
| Disease | in situ carcinoma (is_marker_for) | 3.55e-03 | 21 | 125 | 2 | DOID:8719 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EPPSPTHSLGEGGFF | 261 | Q6UY14 | |
| GHPFPEGAAAEGSAE | 116 | A8MYA2 | |
| EHFSGGEPDVFPTVP | 1491 | P13611 | |
| QHPFGEAAYPADGAD | 141 | Q7Z4R8 | |
| AAFAAGPPGDLHLGT | 6 | O94812 | |
| HDDGQRPSGGAAAAP | 66 | Q8N726 | |
| TFEEHPPFDVPDANG | 341 | O94823 | |
| SFPGGNEEEPGSHLF | 96 | O95450 | |
| DAAAAFPHLAGDPYG | 71 | Q6VUC0 | |
| GPPLHEFDFGLAVEF | 646 | A0A1B0GUU1 | |
| GPNIGGDTHFDSAEP | 206 | P50281 | |
| DHGDNSPFDGPNGIL | 166 | P22894 | |
| LEEGHDFIQEFPGSP | 236 | Q9Y5Y2 | |
| DGAAESPYGHPAGID | 36 | Q12829 | |
| FPLTSAHDPDAGENG | 151 | O14917 | |
| HPDALVGTGFEDDPQ | 446 | Q6ZRP7 | |
| DPAGAAETFHVGLPG | 246 | P52333 | |
| FQADFPLGPATHGGT | 181 | P43631 | |
| FQADFPLGPATHGGT | 276 | P43630 | |
| FQADFPLGPATHGGT | 176 | Q8N109 | |
| AFFHGDLEASPGVPA | 81 | P48050 | |
| KSHFGGPDYEEGPNS | 301 | Q9Y5P4 | |
| FFPGEHPISGDTHFD | 196 | Q9NPA2 | |
| FDGKDGLLAHAFPPG | 181 | P14780 | |
| AFPPGPGIQGDAHFD | 191 | P14780 | |
| PGHEPGGSPQDELDF | 16 | Q13469 | |
| FQADFPLGPATHGGT | 181 | P43627 | |
| FQADFPLGPATHGGT | 181 | P43632 | |
| GDPADEAAALPGHPQ | 6 | P16389 | |
| LPDDSKVPHGPGDFD | 1116 | P10071 | |
| PGDFDAPGLPDSHAG | 1126 | P10071 | |
| EASAAPGHPQDGSYP | 11 | Q09470 | |
| PAGPEFAGHSPGEAA | 151 | A6NFD8 | |
| DDGNFFPGSGAPDEV | 866 | P56524 | |
| LAAAHNPADEPGPGA | 546 | H3BQL2 | |
| AFLAGAAGPLNGDHP | 341 | Q9HCH0 | |
| FQADFPLGPATHGGT | 181 | P43628 | |
| PGQFTVDHGVEPGAD | 101 | Q6JVE5 | |
| FEPATVALPGGEHAE | 406 | Q86UE6 | |
| LRGHGEPQEPGDDFF | 586 | Q86YR5 | |
| PFNPHGGAEPGADSA | 576 | P51511 | |
| APGPGINGDAHFDDD | 186 | P08254 | |
| SYGHELDLGQGPDPS | 941 | Q9UPA5 | |
| GFPEAGPFHVASPEL | 176 | Q9UBV7 | |
| FQADFPLGPATHGGT | 176 | Q8NHK3 | |
| FQADFPLGPATHGGT | 276 | P43629 | |
| GSSTQDPGHPDDPLF | 1206 | O15534 | |
| DPGHPDDPLFSELDG | 1211 | O15534 | |
| EHGDFYPFDGPSGLL | 171 | P45452 | |
| PGPNYGGDAHFDDDE | 191 | P45452 | |
| FLAAAHNSADEPGPG | 546 | H3BV12 | |
| FDVDFPSPGPHGGDK | 2126 | P98088 | |
| WFDIDFPSPGPHGGD | 3231 | P98088 | |
| AAAFAGPPDPLHGNS | 101 | Q96N21 | |
| LGGPEDEPGAAEAHF | 31 | Q68DK7 | |
| ELASVNGHSGDDGPP | 271 | Q86UA1 | |
| EDFEAAGSPFSGGPV | 296 | Q01860 | |
| GTFQADFPLGPATHG | 176 | Q99706 | |
| HGAPLVPIFSFGEND | 216 | Q3SYC2 | |
| FLHEDPAAGAAPGLG | 66 | Q58A45 | |
| PDFFSAALHPGGEPL | 781 | Q9Y4H2 | |
| GDSALDREAHPFPGQ | 251 | A6NGY1 | |
| GVFFPSGPEGLDAAA | 31 | P15976 | |
| FFADSGADPKGEPGS | 311 | Q8TES7 | |
| FPGPAGPSFNSTEDH | 281 | O00115 | |
| LPHAGGEDHGEEPNY | 116 | Q5SZD1 | |
| LPFHPPGDTAQDGEL | 496 | O75460 | |
| PRAHGEGLPDQSFED | 571 | Q9BQW3 | |
| QDPAFGGKHEAPSSP | 36 | Q9H4R4 | |
| GPHSPDPLLDEQAFG | 171 | Q9H3Q1 | |
| FLAAAHNSADEPGPG | 546 | A6NMD2 | |
| GPDPSANPFHLSGDV | 46 | Q494V2 | |
| GGTDNPHIGDDPSIF | 81 | P78352 | |
| SHPEPPAGFEGLQAE | 1721 | Q14767 | |
| FLAAAHNSADEPGPG | 546 | P0CJ92 | |
| AGHDPAPEGQADYDP | 571 | Q9HBG7 | |
| LPNFHAGTEPDGLDP | 146 | Q8NDX9 | |
| DPTVHDGPDRGYVFG | 411 | Q92551 | |
| LPGGDPNHVTDDFAA | 116 | Q9P0J7 | |
| PPGHPDAINFDDSGV | 336 | O60381 | |
| SIAGGTDNPHIGDDP | 111 | Q15700 | |
| GFSAAAAPDPDDPFG | 36 | Q8WXE1 | |
| AAPDPDDPFGAHGDF | 41 | Q8WXE1 | |
| VSAGFDAAEGHPAPL | 796 | Q8WUI4 | |
| LEELPNDVFHGASGP | 206 | P23945 | |
| FLAAAHNSADEPGPG | 546 | A6NCC3 | |
| SPPLGAGLADFAHPA | 401 | O75052 | |
| AGLADFAHPAGSPLG | 406 | O75052 | |
| GVPLHGGDEDRPFPD | 121 | Q6UWU4 | |
| AGFADPDDFTLGAGP | 481 | Q6ZRV2 | |
| PDGAPEHAAPGEGAE | 21 | Q9BXA9 | |
| FQADFPLGPATHGGT | 181 | P43626 | |
| FIHVDFDPPGPLSAG | 561 | Q9C0B2 | |
| DPSEEGPGDFGFLHA | 186 | Q14154 | |
| NDDLSAPGREPGHFN | 771 | Q32MZ4 | |
| PHSGPDLGISFDQFG | 246 | Q86XI6 | |
| AGRSPEEAGFPGDPH | 111 | Q8IV56 | |
| DDLPFDGPGGILAHA | 166 | P24347 | |
| AHGTPGSEAGPEELN | 16 | Q96HJ5 | |
| PGHVLLEDPDSGFFF | 1766 | Q5T011 | |
| DPDASGPQFHQAAGE | 3381 | P46939 | |
| HPGHAEGREGDFPAA | 126 | Q8IYL2 | |
| AGLSGDDPDLGPAHV | 246 | Q9BTV4 | |
| DPPAGSAPGEHVFVK | 456 | P54577 | |
| DHPAEPPVAFGRAGA | 846 | Q9HCJ0 | |
| SSEGHSPGPFFDPEF | 206 | A6NEV1 | |
| FDGAEPGPPYTTDEH | 466 | P28370 | |
| QPGPGIGGDAHFDED | 186 | P03956 | |
| FDGPTGELAHAFFPP | 161 | O75900 | |
| EAGLCLDPGPPSHAF | 401 | Q8N2H9 | |
| GIFPKDGSGDSHPDF | 191 | Q08752 | |
| DENGHDLAVTFPGPG | 231 | O14793 | |
| FLAAAHNSADEPGPG | 546 | H3BSY2 | |
| FQADFPLGPATHGGT | 276 | Q14943 | |
| DPAFGGKHEAPSSPI | 146 | O75376 | |
| GPHSSPPEEKGAFGD | 736 | O75182 | |
| GVPPPLENGFHSADD | 1691 | Q4LDE5 | |
| PPEDLAHGFPNGFSF | 2951 | Q4LDE5 | |
| GLDPNFHDPETGETP | 186 | Q9UPX8 | |
| FGAEHDPDGLAECAP | 411 | P78536 | |
| HGFITPADGGPDIFL | 76 | Q9Y2V2 | |
| DEGFGAPAGSHAAPA | 41 | P09497 | |
| ALDGGEPHGVPAFPD | 271 | Q5BKX6 | |
| DPLDPTDLNGAHFDP | 56 | Q9UID3 | |
| PAPDVLEFTDHGGSG | 296 | Q9UID3 | |
| PSKGGNFPSFPHDEV | 91 | Q9UHF7 | |
| PSDHLGDLGDPFHLG | 506 | P19532 | |
| DPRFTGSFDDDPDPH | 1321 | O15027 | |
| GSFDDDPDPHRDPYG | 1326 | O15027 | |
| EFDHLPDPQEGPGSD | 961 | Q76I76 | |
| AGHPNPGSFPEFVEK | 146 | P49888 | |
| LPEGVTDDGVFPGDH | 516 | Q9Y5Y9 | |
| DGPAAEAEPEHSFDG | 2771 | Q15149 | |
| HDGPVAGLAFDLNEP | 596 | Q99835 | |
| DQPHRGAPAPEAFGS | 1756 | Q96JG9 | |
| GAPAPEAFGSPAVHL | 1761 | Q96JG9 | |
| HPTAGRPGFEGNEFA | 1816 | Q96JG9 | |
| DFPDSFQAGSPGHLG | 206 | A1YPR0 | |
| PRPHQPSGGGDDFFL | 76 | P98168 | |
| GPAPHDQELGFFLET | 206 | Q86TV6 | |
| DLFAHFGPEPGDHSD | 161 | Q8N1G0 | |
| VPGPGGAETHFDQLE | 296 | Q9NS98 | |
| AASDGDGDAGQPPLH | 1411 | P52746 | |
| EGAYEHPGSSLFPEG | 2191 | P31629 | |
| GPDFPAGAHRAEDSI | 1266 | Q702N8 | |
| PVPGDGLHRAGFDAF | 431 | Q96GM8 | |
| GHLAPSPPAFDGELD | 11 | Q9P2Y4 | |
| EPPFAPRSGDAHYGA | 301 | Q96T25 | |
| FLAAAHNPADEPGPG | 546 | A6NC78 | |
| FLAAAHNSADEPGPG | 546 | F8WBI6 | |
| SPPEDFCPHVGAAGA | 56 | Q9Y6N6 | |
| DGFFGDPLGLFGHPQ | 791 | Q9Y6N6 | |
| PDPGPAGHTLFQDVF | 31 | Q96P71 |